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November 27, 1967

To Members of the Forty-sixth Colorado General Assembly:
In accordance with provisions of Senate Joint
Resolution No. 42, 1967 session, the Legislative Council
submits the accompanying report and recommendations relating to the subject of dangerous drugs and drug abuse
in Colorado.
The report and recommendations of the committee
appointed to carry out this study was accepted by the.
Council at its meeting on November 27, 1967, for trans- _
mission to the members of the second regular session of
the Forty-sixth General Assembly. The Legislative
Council has requested that the Govemor include the
recommended bill among the items for consideration in
the second session of the Forty-sixth General Assembly.
Respectfully submitted,

'/:: ;;: #

RepM;ttt~ C. P. Lamb
Chairman
CPL/mp
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November 20, 1967
Representative C. P. Lamb, Chairman
Colorado Legislative Council
Room 341, State Capitol
Denver, Colorado
Dear Mr. Chairman:
In accordance with the provisions of Senate Joint Resolution
No. 42, 1967 session, your Committee on the Criminal Code was appointed to continue the work on revision of Colorado criminal laws,
to review recommendations of the President's Commission on Crime,
to study all aspects of sentencing of offenders, and to make recommendations concerning the need for legislation controlling dangerous
drugs and drug abuse in Colorado.
Although the committee is not required to report its findings
and recommendations until 1969, its work has been completed in regard to dangerous drugs and drug abuse, and the committee submits
the accompanying report and recommendations to the Legislative
Council. Because of the seriousness of the drug abuse problem and
the need for the state to begin drug treatment programs as well as
drug control measures, the committee recommends that the Legislative
Council request that the Governor place this subject in his call to
the 1968 session of the General Assembly.
The committee has agreed to submit one bill to control the
manufacture, sale, distribution, and possession of certain stimulant, depressant, and hallucinogenic drugs. In addition, the bill
has been prepared to allow the courts the widest possible latitude
in providing treatment of persons who possess these dangerous drugs
for personal consumption.
Re~p. e. )tfullyl'·~~.mi/tted\··•
/
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Repre~entative Raymond E. Wilder
Chairman
Crimi~al Code Committee
REW/mp

FOREWORD

The Legislative Council's Criminal Code Committee was created pursuant to the provisions of Senate Joint Resolution No. 42,
1967 regular session, to study revision of Colorado's criminal laws,
to review recommendations made by the President's Commission on
Crime, to consider all aspects of sentencing of offenders, and to
make recommendations concerning the need for dangerous drug legislation. The members appointed to the committee were:
Rep. Raymond E. Wilder,
Chairman
Rep. Ben Klein, Vice
Chairman
Sen. David Hahn
Sen. Ruth Stockton
Sen. Anthony F. Vollack

Rep.
Rep.
Rep.
Rep.
Rep.
Rep.
Rep.

Thomas Bastien
Ted Bryant
John Fuhr
J. D. Macfarlane
Phillip Massari
Harold McCormick
Hubert M. Safran

Representative C. P. Lamb, Chairman of the Legislative Council,
also served as an ex officio member of the committee.
Early in the committee deliberations, the members agreed
that the assignment in Senate Joint Resolution No. 42 was greater
than could be undertaken at one time. Therefore, the committee
decided to concentrate its efforts first on the subject of drugs and
drug abuse, since this topic was the only assignment which called
for specific legislative recommendations.
The committee wishes to express its appreciation to the
numerous local, state, and federal officials, and to the several
professional persons who conferred with the committee on the dangerous drug problem.
Phillip E. Jones and Stanley Elofson, senior research analysts for the Legislative Council, had the primary responsibility for
the staff work on this study, with the assistance of Ed Isern, research assistant. James C. Wilson, Jr., and Robert Holt, assistant
attorneys general, Legislative Reference Office, had the primary
responsibility for bill drafting services provided the committee.

Lyle C. Kyle
Director

November 28, 1967
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CONMITTBE FINDINGS AND RSCOMMBNDATl~S
The Legislative Council'• Criminal Code Co•ltte• waa ••i•b•
liehed pureuant to Senate Joint Reeolution No. 42 (1967 Se11ton)
which directed the Council to conduct a study to ,utMalt Hport, and
reco•endationa pertaining to problems of drug abu1e in Colorado.
The atudy of drug abuse wa1 to include the following 1ubject11
(l) The collection of information and the dev.lopaent ef
recommendation• pertaining to the eff.e ctivene11 of Pf•••nt stat•
,tatutes and the relation1hip of atate law to federal acts in the
area of drug control;
(2) The poasible need for additional at•te legi1lation to
provide effective control over illicit drug traffic, drug abU1e, and
drug addiction;

(3) The determination of the moat 1uitable approach of stat•
legislation toward the problem of the control of non-narcotic drllf••
including stimulants, depressants, and hallucinogenic drugas
(4) Consideration of the appropriate typea of reaea~ch and
educational programs that should be undertaken conceming the effect,
of auch druga upon the human body; and
(5) A review of the exi1ting treatment facilities avallablt
for drug users and addicts and the poesible need for additional
therapeutic facilities to provide more effective control over th• ~.
uae of drug• within the atate.
~ ·

Although the report of the Criminal Code Committee is not due until
the 1969 session, the topics listed above have been carefully reviewed by the Criminal Code Committee and are considered to be of
such importance that they merit consideration by the General Assembly
in the 1968 session.
In addition to the drug problem, the assignment to the Legia•
lative Council in S.J.R. 42 directed studiea in three other major
areas of concern to the criminal laws in this state:
(1) A study to determine whether legislative efforts to revise and codify the state's criminal laws should be continued, with
a request being made of members of the Colorado Bar Aasociation,
faculty members of the law schools in this state, and other interested persons to evaluate the contents of the preliminary criminal
1aw revision published in 1964 by the Legislative Council.
(2) A 1turly to review the report of the President's Coaala•
1lon on Cri• and to reco11111end appropriate action that should be
taken by the General Assembly to implement the findings and conclu~
1ion• contained in the report at both the state and local levels of
govern•nt.

xi

(3)

A study of all aspects of the subject of sentencing of
offenders, including a review of action taken in the First Regular
Session of the Forty-sixth General Assembly that would have a bearing on the issue of indeterminate sentencing of offenders.
It is the committee's plan to study the three remaining subjects
next year and to submit its report and recommendations on these
topics for consideration in the 1969 session.
Because the problem of drug abuse was the only specific topic
directed under S.J.R. No. 42, the committee decided at its June 8
meeting to undertake its study of the drug abuse problem in Colorado
as its first matter of concern. The next meetings, June 28 - 29,
July 18, and September 7, were devoted to hearings on drug abuse.
Conferees at these meetings represented training in a variety
of professions, academic disciplines, and practical experiences with
problems of drug abuse throughout the country and in Colorado. Some
strong differences of opinion characterized the statements of the
conferees in regard to the proper approach of state legislation to
the drug abuse problem. Much of the information in this report was
provided by the conferees. An outline of some additional viewpoints
of these conferees is included in the background report which follows the committee's report. A listing of the conferees and their
responsibilities follows:
Mr. John A. Trainor, Denver Office District Supervisor,
Bureau of Narcotics, U.S. Department of Treasury
Mr. John Healey, District Supervisor, Bureau of Drug·
Abuse Control, Food and Drug Administration, U.S.
Department of Health, Education and Welfare
Mr. Donald Fletcher, Manager of Distribution Protection, Smith Kline & French Laboratories, Philadelphia,
Pennsylvania
Dr. Hans Schapire, Chief of Psychiatric Services,
Colorado Department of Institutions
Mr. Harry Tinsley, Chief of Corrections, Colorado
Department of Institutions
Mr. Edward W. Grout, Executive Director, Division of
Adult Parole, Colorado Department of Institutions

Dr . Lewis Barbato, Director, Health Services, University of Denver
Dr. Alan Frank, Psychiatrist, Student Health Services,
University of Colorado
Mr. Lester Thomas, Director of Research and Programming,
Denver County Court
xii
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Mr. John Gray, Detective, Intelligence Bureau, Denver
Police Department
Mr. Leonard Davies, Attorney, Neighborhood Law Center,
Denver
Mr. Orlen Wiemann, Chief, Milk, Food, and Drug Section,
Colorado Department of Public Health
Professor Richard H. Blum, Project Director, Psychopharmacology Project, Institute for the Study of Human
Problems, Stanford University
Dr. H. Peter Metzger, Research Associate, Department of
Chemistry, University of Colorado

Mr. Joseph C. Arnold, Minister, United Church of Christ,
Denver
Need for Additional State Legislation to Control Dangerous Drugs

Because of an apparent rapid growth of drug abuse in Colorado,
particularly by adolescents, the committee has concluded that there
is a definite need for state legislation to control dangerous
drugs •.!/ Reliable figures on drug abuse growth are virtually impossible to obtain for a number of reasons, and any statistics that
are presented should be carefully analyzed before being accepted.
Both proponents and opponents of the use of dangerous drugs tend to
exaggerate the figures on the number of people using these drugs as
a method of asserting their cause. However, as one indication of
significant drug use in Colorado, hardly a day passes without an
article in the newspapers concerning drug abuse arrests or statements
concerning drug use.
The federal government presently controls interstate and intrastate manufacturing and distribution of dangerous drugs through
the Bureau of Drug Abuse Control, Department of Health, Education and
Welfare. While the federal government can confiscate dangerous
drugs, federal statutes provide neither penalties nor treatment programs for individuals possessing these drugs. One of the limitations
in relying exclusively on the federal government for enforcement of

y

The term "dangerous drugs," as used in this report, refers to
depressant, stimulant,and hallucinogenic drugs but does not refer to narcotic drugs which are considered as a separate category. A description of these drugs is found on page xv of the
committee report and pages 4 through 6 of the background report.
xiii

drug abuse laws is that there are relatively few federal agents

available to control all aspec~s of dangerous drug abuse. Speaker&
from federal agencies urged the committee to recommend state legislation in order to provide for increased manpower and for sharing of
information between federal, state, and local authorities.

It would not be realistic to suggest that state legislation
on dangerous drugs, even coupled with existing federal laws, will
eliminate or prevent future problems of drug abuse in Colorado. As
members of the General Assembly are aware, legislation in dangerous
drugs control is difficult because of the potential for misuse of
practically any substance. It was pointed out to the committee that
legislation to control drug use will always lag behind many new
drugs with which young people will experiment.
However, Professor Richard H. Blum of Stanford University
pointed out that legislation can retard the expansion of drug abuse
in two ways. First, the availability of dangerous drugs can be reduced through legislation. Further, legislation can establish legal
restrictions which many persons will not want to violate. The committee believes that legislation to retard further extension of the
use of dangerous drugs is a matter for serious legislative attention. The problem, however, becomes one of deciding on the most
appropriate course of action in the control of drug abuse.
Alternative Solutions to the Dangerous Drug Abuse Problem
The committee concluded that it had the choice of recommending four alternative approaches for legislation. The first alternative would be to maintain the status quo, or make no recommendations.
The committee felt that making such a recommendation would be an
irresponsible position because of the apparent growth of drug abuse
in Colorado. Although there is much yet to be learned concerning
long-term effects of dangerous drugs on the human body, the potential dangers and misuse of these drugs outside of laboratories seems
sufficient reason to legislate against manufacture, sale, and distribution of these drugs.
A second alternative for legislation could be to simply add
a list of dangerous drugs to the existing statutory definitions of
narcotic drugs in section 48-5-1, C.R.S. 1963. This approach would
place dangerous drugs in the same category as narcotic drugs with
the same penalties for narcotic drugs also applying to dangerous
drugs. The committee rejected this alternative because of the
severity of penalties in the narcotic statutes. It was thought that
the majority of the dangerous drug offenders were young people who
are potentially productive members of society, but who may be in
need of guidance, counseling, and treatment, and who probably do not
realize the significance of a felony stigma. Society probably
would gain nothing by making these adolescents and young adults
felons. Once a person is convicted of a felony, the stigma is present for the rest of that person's life, and his productive capabilities for further education and future employment might be lost.
xiv
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The third alternative discussed by the committee was to prepare an all-inclusive drug bill. This alternative could combine
narcotic drugs and dangerous drugs in one act but could have separate penalty sections for narcotic drugs and dangerous drugs. One
potential difficulty which an all-inclusive act could avoid would
be possible duplication of duties by two different governmental
agencies. This situation is present on the federal level with the
Bureau of Narcotics in the Department of Treasury controlling narcotics andthe Bureau of Drug Abuse Control established under the
Department of Health, Education and Welfare working with dangerous
drugs.
The committee believes that a single narcotic-dangerous drug
act would present the General Assembly with the same controversy
which the committee constantly faced, namely whether marihuana
should be listed in the dangerous drug classification or should be
left in the narcotics classification. As discussed later, there are
reasons for arguing for removal or for the retention of marihuana
in the narcotics statutes, but the committee's recommendation is
that the dangerous drug bill be enacted regardless of any other legislative action in regard to marihuana.
The fourth alternative, which the committee felt to be the
best course of action, is a drug abuse act, separate from the narcotic act, controlling dangerous drugs only. The important features
of the bill which the committee recommends are discussed next.
Important Features of the Recommended Drug Abuse Control Act
The committee basically adopted the provisions of the Model
Drug Abuse Control Act promulgated by the U.S. Department of Health,
Education and Welfare. This act has been enacted in 14 other states
(see Item B in the appendix). The proposed drug abuse control act
for Colorado corresponds closely with the federal law on dangerous
drugs. This uniformity makes it easier for legitimate manufacturers,
wholesalers, and distributers, which are required to be licensed, to
comply with the provisions of the dangerous drug law. Better cooperation between state& and local authorities and federal officers
can be achieved if state legislation is in agreement with federal
law.
Controlled Dangerous Drugs. !he dangerous drugs controlled
by the recommended act include a number of specified depressant
drugs (sleep inducing dru9s), stimulant drugs (drugs which induce
alertness and wakefulness), and hallucinogens (drugs which distort
perceptions of the mind). The list of controlled drugs in each
category is taken from federal statutes and from the federal regulations of the Food and Drug Administration which is authorized by
federal law to list additional drugs having a potential for abuse
because of their depressant, stimulant, or halluc5nogenic effect.
The sources for the drugs listed in the three categories are noted
in the comment portion of the bill which follows thi~ report. It
was necessary to specify the controlled drugs in the bill instead

xv

of permitting the administrative authoritiea to prepare the danger•

oua drug liat. This procedure will avoid a constitutional question
of unlawful delegation of authority, since the proposed bill includes criminal penalties.
Two exceptions to these claaaificationa of drugs ahould be
noted. Cocaine, a strong stimulant! is included in the narcotic
drug category rather than in the st mulant drug claasification.
However, cocaine may produce possible toxic reactions so it is seldom abuaed and presents no controversy.
The committee was divided on the question of whether to leave
marihuana as a narcotic drug or to reclassify it as a hallucinogenic
drug in the dangerous drug bill. Votes on this question were taken
on four occasions in committee meetings, the result of three of the
votes being not to reclassify marihuana as a dangerous drug. The
committee recommendation is that marihuana be left unchanged in the
narcotic drug classification at least until the issue is clarified
on the basis of further research by the federal government.
Several arguments for and against retention of marihuana
under the state's narcotic law were presented to the committee. Individuals advocating a raclassification of marihuana as a dangerous
drug point out that marihuana is a narcotic by legal definition
only. Pharmacologists have stated that marihuana is a mild hallucinoger., much weaker than LSD which is classified as a dangerous hallucinogenic drug in the proposed bill. It was also stated that both
alcohol and cigarettes may be potentially more dangerous than marihuana.
Arguments for leaving marihuana in the narcotics listing were
that every other state has defined marihuana as a narcotic drug and•
evm though the federal law has not defined marihuana as a narcotic
drug, marihuana is treated the same as a narcotic drug. If marihuana were made a dangerous drug, jurisdictional disputes could develop between the federal Bureau of Narcotics and the state. Therefore, until the federal government reclassifies marihuana, it would
not be practical for Colorado to place marihuana in the dangerous
drug category. Two important features of drug control laws are
uniformity in statutes and cooperation between state and federal
officers. Further, removal of marihuana to the dangerous drug
category, with weaker penalties than the narcotic laws, might be
misinterpreted as an expression of tacit approval for the use of the
drug. After much deliberation, the committee decided not to recommend reclassifying marihuana for the reasons discussed above.
Unlawful Acts. The proposed bill would make illegal manufacturing, sale or aistribution, and possession of dangerous drugs
unlawful acts. To assure that control over these drugs is maintained, the bill includes regulations for making detailed prescriptions for legal possession. All manufacturers, wholesalers, and
anyone else handling these drugs would be licensed or registered
under this act except for physicians, pharmacists, dentists, and
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veterinarians who are licensed by their respective professional licensing boards. Everyone licensed under this act or by a professional licensing board would be required to keep records of sale of
dangerous drugs for two years, and these records of sale and all
inventory supplies would be open to inspection to authorized state
officials. These provisions would assist in controlling both production and distribution of dangerous drugs. Anyone violating any
of the record keeping requirements or licensing procedures could
have his professional license or the license issued under this act
suspended or revoked.
Penalties. The committee agreed that the most significant
problem in dangerous drugs was to dry up the illicit sources of
dangerous drugs. Strict criminal sanctions should be applied for
the illegal manufacture, sale, possession with intent to sell, and
the attempt to sell any listed dangerous drug. These offenses
should be felonies with possible imprisonment in the state penitentiary from one to fourteen years and a fine of up to $1,000.
The penalty for unlawful possession, however, was a problem
of great concern to the committee. During the hearings several experts in the field of dangerous drugs testified that a great majority of the drug users were adolescents or young adults who took
drugs on an experimental basis. Many of these persons may take drugs
one time as a method of adventuring into the world away from parental control. The young people who continue to use dangerous drugs
were said to do so primarily because of some deep-seated emotional
problem. Young persons using drugs should not be deterred from seeking medical assistance because of fear of criminal penalty.
With this background in mind, the committee provided three
penalties for unlawful possession of dangerous drugs. The first two
offenses would be misdemeanors with several alternative provisions
for education and treatment of the offender. For the first offense
the judge would have the alternatives of (1) sentencing the offender
to county jail, (2) fining the offender, (3) both fine and sentence,
(4) granting probation, (5) granting conditional probation, (6)
deferring trial in case of voluntary commitment for treatment, and
(7) proceeding under civil (involuntary) commitment. For the second
offense a person could be (1) sentenced to the county jail for a
period of time up to two years, (2) fined up to a maximum of $1,000
or (3) both imprisoned and fined. The judge is also given authority
to (4) place the defendant in the care and custody of the department
of institutions (involuntary civil commitment), or (5) to grant probation. The third offense is a felony with provisions for imprisonment in the state penitentiary for a period of from one to fourteen
years, or to provide for involuntary commitment, or grant probation.
The committee believes that legislation to control the availability of dangerous drugs by strict penalties for illegal drug
production and distribution represents a better use of the limited
manpower for police purposes than prosecuting drug users.

xvii

other Committee Recommendations
Education. During the hearings in June and July, every conferee pointed out that society as a whole lacks the proper knowledge
about the dangers of drug abuse. It was stated that the United
States has become a "pill addicted socei ty" in which drugs are used
when persons catch cold, become nervous, or gather socially, (alcohol is a depressant drug). It should not be unexpected that young
people are using drugs, since they are imitating their parents. The
primary difference is that parents use legal drugs and young people
use exotic illegal drugs.
It would be impossible to educate all of society; however,
several segments of society can be educated. For example, medical
doctors are the leaders in forming drug habits through prescribing
drugs and need to be informed of drug abuse trends. Police officers
have been given the impossible task of controlling drug traffic and
use. However, there is need for more training for police officers
particularly in regard to the effects of drugs, why people use drugs,
and the availability of treatment facilities. The committee was told
that the police are directed to get the drug abuser off the street,
and with the limited tool of arrest available to them, they have done
a good job. However, this approach does not keep the drug abuser
off the street permanently.
Finally, school children need a good drug education program
in the schools. It was emphasized to the committee that young people
often do not understand that drug use can be dangerous. An educational program should start in the latter years of elementary school
with at least one hour per semester and should be taught by•well informed teachers using factual, ·current information. Several sources
of materials for schools were mentioned as being available for the
teaching of a well rounded and factual drug education program.
State Laboratory. Federal authorities suggested that Colorado
establish a laboratory available to law enforcement agencies for
drug identification, possibly under the supervision of the Colorado
Bureau of Investigation. Law enforcement agencies currently have to
send drug samples to the laboratories of the Federal Bureau of Investigation, the Bureau of Narcotics, the Bureau of Drug Abuse Control, or the Denver Police Department. Often these agencies are not
able to immediately analyze drug samples, and a long delay in receiving the analysis may mean that a drug case is dismissed or the
defendant loses his right to a speedy trial.
Narcotic Dru s. The 1960 Federal Narcotics Law, "Narcotic
Manufacture Act of960," removed from the exempt list dihydrocodeinone. In Section 48-5-8, C.R.S. 1963, dihydrocodeinone is still
exempt. Since federal law takes precedence, Colorado should revise
Section 48-5-8 to conform with federal law.

1

Treatment Facilities. Colorado is a growing state, and
growth can bring narcotic problems. The treatment facilities in
xviii

Colorado are limited to some emergency treatment facilities, one
facility for treatment of acute withdrawal symptoms, which is more
than most states have, and the Colorado State Hospital for controlled withdrawal and therapy.
The committee recommends that a specialized facility be established for treatment of narcotic addicts and persons needing care
for the use of dangerous drugs. This drug treatment ward should be
separate from other treatment facilities and should be staffed by
persons interested and skilled in the treatment of drug addiction
and dependency. It is further suggested that this facility be located in the Denver area so that it will be accessible to the largest
population center in the state in providing both inpatient and ambulatory services.
A major deficiency in the st~te's treatment program is the
lack of aftercare facilities close to an addict's home. When the
addict returns to the same environment where he became addicted, he
will become readdicted when the problems of his environment again
present themselves. The American Medical Association supports a program of withdrawal in a controlled drug free environment, and a full
program of aftercare, including regular and surprise physical tests
on the addict. Much of the aftercare work can be carried on by the
state's social services. To aid the states Congress passed the
"Narcotic Rehabilitation Act of 1966," which makes funds available
to the states to build and maintain treatment facilities. Colorado
should take advantage of these funds.
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Q)M\fENTS
A BILL FOR AN ACT

CONCERNING CERTAIN DRUGS NOT REGULATED BY ARTICLE 5 OF
CHAPTER 48, COLORAOO REVISED STATUTES 1963 AS AMENDED,
AND PROVIDING FOR THE REGULATION OF CERTAIN DEPRESSANT, STIMULANT, AND HALLUCINOGENIC DRUGS AS DEFINED
IN THIS ACT.

h ,.ti enacted !ri the General Assembl"( 91..

-rado: SECTION 1.

Definitions.

~

State ll Colo-

(l) As used in this act,

)(

....X

unless the context otherwise indicates:
(2) (a)

(b)

woepressant drugsfl means:

Barbituric acid, allylbarbituric acid, aprobar-

bital, beta-bromoallyl, secondary - amylbarbituric acid,
butallylonal, diallyl barbituric acid, barbital, hexobarbital, dipropylbarbituric acid, butethal, butabarbital,
cyclobarbital, hexethal, amobarbital, pentobarbital, thiopental, vinbarbital, mephobarbital, propallylonal, phenylmethylbarbituric acid, secobarbital, phenobarbital, probarbital, and their salts; and

The sour-::;• for all enumerated
drugs is ~ne Code of Federal
Re~ulations, Title 21, parts
16 and 166. This drug list
will need to be updated annually by the General Assembly
as new drugs are cont.rolled
by the Food and Dru9 Administration. These additional
drugs will be listed in the
Federal Register and Code of
Federal Regulations.

□
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(c)

Bromal hydrate, bromoform, tribromo, chloral

hydrate, chloralimide, chloralformamide, chloralose, chlorbutanol, acetylcarbromal, bromisovalum, diethylbromo acetamide, ethchlorvynol, ethinamate, glutethimide, methyprylon,
paraldehyde, lysergic acid, lysergic acid amide, chloral
betaine, chlorhexadol, petrichloral, sulfondiethylmethane,
sulfonethylmethane, sulfonmethane.
(3)
X

><
........

"Stimulant drugs" means d-amphetamine, del-amphe-

tamine, d-methamphetamine, dl-methamphetamine, d-desoxyephedrine, dl-desoxyephedrine, and phenmetrazine, and their
salts.
(4)

"Hallucinogenic drugs" means dimethyltryptamine,

d-lysergic acid diethylamide, mescaline and its salts,
peyote, psilocybin, and psilocyn.
(5)

•Dangerous drug" shall mean depressant drugs,

hallucinogenic drugs, or stimulant drugs, or any of such
drugs in a mixture, compound, or with any . other substance.
(6)

"Practitioner" means a person authorized by the

laws of this state to practice medicine, veterinary medicine,

Under the pharmacy laws of
this state, the board of pharmacy has control, by inspection, over-all prescription
drugs, which include many stimulants and depressants. However, this control is limited
to the retail level, including
institutional pharmacies. Physicians are excluded from inspection by the state board of
pharmacy and manufacturers,
wholesalers, and warehousemen
are not now regulated under
Colorado pharmacy laws. These
persons would be regulated
under this act insofar as the
specific drugs listed in the
act are concerned.
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or dentistry, in this state or any other person who is authorized by the laws of this state to prescribe drugs.
(7)

"Pharmacist" means a registered pharmacist as

defined by the laws of this state, and, where the context
requires, the owner of a sto~or other place of business
where drugs are compounded or dispensed by a registered
pharmacist; but nothing in this subsection shall be construed
as conferring on a person who is not registered nor licensed
as a pharmacist any authority, right, or privilege, that is
not granted to him by the pharmacy laws of this state.
(8)

"Manufacturer" means a person who by compounding,

mixing, cultivating, growing, or other process, produces
or prepares dangerous drugs for dispensing, but does not
include a pharmacist who compounds dangerous drugs to be
sold or dispensed.
(9)

•wholesaler• means a person who dispenses, with-

out prescription, dangerous drugs that he himself has not
prepared or produced.
(10)

•·. Warehouseman" means a person who stores or
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dispenses dangerous drugs for others and who has no control
over the disposition of such drugs except for the purpose
of such storage or dispensing.
(11)

"Carrier" means any person who transports danger-

ous drugs iu the ordinary course of his business for any
person required to be licensed pursuant to section 6 of this

act.
(12)

•clinical researcher• means · any person licensed

pursuant to section 6 of this act to experiment with, study,
or test any dangerous drug within this state.
(13)

"Hospital• means an institution for the care and

treatment of the infirm, sick, and injured, approved by
an agency· of this state to be entrusted with the custody.of
narcotic drugs and the professional use of narcotic drugs
under the direction of a practitioner.
(14)

•Person• means an individual, partnership, corpo-

ration, or association.
(15)

"Dispense• means sale, delivery, giving away, or

supplying in any other manner, or otherwise disposing of
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to another person.
(16)

•soard• means the state board of pharmacy.

SECTia-J 2.

Unlawful acts.

(1)

Except as provided in

section 3 of this act, the following acts are hereby declared

unlawful.
(2) (a) To diapense any dangerous drugs unless:
(b)

Such dangerous drug is dispensed by a pharmacist,

upon a prescription~ and there ia affixed to the immediate
.•

container in which such drug is dispensed a label bearing:
X

~

(i)

The name and address of the phamacy from which

such drug was dispensed;
( 11)
(iii)

The name of the pharmacist dispensing the drug;
The date on which the prescription for such

drug waa filled;

(iv)

The number of such prescription as filed in the

prescription files of the pharmacist who filled such prescription:
(v)
drug;

The name of the practitioner who prescribed such

Requirements for labeling
prescriptions.

(vi)

The name and address of the patient, and, if

such drug was prescribed for an animal, the name and address
of the owner and a statement of the species of the animal;
and
(vii)

The directions for use of the drug as contained

in the prescription.
(c)

Such dangerous drug is dispensed by a practitioner

in the course of his practice, and the immediate container
X
X

<
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in which such drug is dispensed bears a label on which appears the directions for use of such drug, the name and
address of such practitioner, the name and address of the
patient, the date, and, if such drug is prescribed for an
animal, the name and address of the owner and a statement of
the species of the animal.
(3)

To fill or refill any prescription for any danger-

ous drug more than six months after the date on which such
prescription was issued, and no such prescription which is
authorized to be refilled may be refilled more than five
times, except that any prescription for such a drug after
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six months after the date of issue or after being refilled
five times may be renewed once orally by the practitioner
issuing it, if such renewal is promptly reduced to writing
and filed by the pharmacist filling it, and the original
prescription shall be cancelled.

If no indication of refill

status i .s indicated on the prescription, it shall not be refilled.
(4)
x

To dispense a dangerous drug upon prescription

unless the pharmacist who filled such prescription files

)(

<

....,...

and retains it as required in section 4 of this act •
(5)

The possession of a dangerous drug by any person,

unless such person obtains such drug from a pharmacist on
prescription of a practitioner or in accordance with paragraph (2) (c) of this section.

The possession of any such

drug which is not in a container labelled in accordance
with the requirements of subsection (2) of this section shall
be prima facie evidence that such drug was not lawfully in
the possession of the person possessing it.
(6)

To manufacture for dispensing any dangerous drug

without first obtaining a license pursuant to section 6 of
this act.
(7)

The refusal to make available and to accord full

opportunity to check any record or file as required by section 5 of this act.
(8)

The failure to keep records as required by section

4 of this act.
(9)
~

<

The failure to obtain a license as provided for in

section 6 of this act, or the violation of the terms of any
such license.
SECTION 3.

Exemptions.

(1) (a)

The provisions of sub-

sections (1) through (6) of section 2 of this act shall not
apply to the dispensing of dangerous drugs to persons included in any of the classes named in paragraphs (b) through

(f) of this subsection (1), or to the agents, employees, or
carriers of such persons, for use in the usual course of
their business or practice, or in the performance of their
official duties, as the case may be; or to the possession
of such drugs by such persons or their agents, employees,
or carriers for such use:

(b)

Pharmacists and practitioners licensed to practice

or do business in this state;
(c)

Persons who procure such drugs for handling by or

under the supervision of pharmacists and practitioners employed by them;
(d)

Hospitals which procure such drugs for lawful ad-

ministration by practitioners;
(e)
)(
)(

....

)(

Officers or employees of appropriate agencies of

federal, state, or local governments, pursuant to their official duties;
(f)

Licensed manufacturers, wholesalers, clinical re-

searchers, and warehousemen of such drugs.
(2)

All combination drugs enumerated as being exempt

in the Federal Register, Vol. 32, No. 5, January 10, 1967, pp.
197-203 and as amended in the Federal Register, Vol. 32, No.
56, March 23, 1967, pp. 4406-4407, are exempt from the provisions of this act.
(3)

Provisions of subsections (1) through (6) of

section 2 of this act do not apply to peyote if said drug
is used in religious ceremonies of any bona fide religious

organization incorporated under the lan of this state.
SECTic»l 4.

Inspection of stock and

records.

(1)

Any

dangerous drug in the posseseion of a manufacturer, wholesaler, carrier, warehouseman, clinical re1earcher, .pharmacist,or practitioner, shall be, during business hours, open

drugs shall, upon the presentation and delivery of written
request of an inspector or employee duly designated by the
board or a law enforcement officer of any political subdivision of this state, and after proper showing of credentials,
make such files or records available to such officer, inspector, or employee, at all reasonable hours, for inspection
or copying, and accord to such officer, inspector, or employee
full opportunity to check the correctness of such files or
><

records.

X

~)(

SECTION 6.

License required - fee.

(1)

No person

shall experiment with, study, or test any dangerous drug
without first obtaining a license as a clinical researcher

Subsections (1) and (2) of
section 6 requires clinical
researchers and manufacturers
to be licensed by the provisions of this act.

from the board.
(2)

No person knowingly shall produce, or process, or

manufacture, any dangerous drugs, for sale in this state
without first obtaining a license as a manufacturer of dangerous drugs from the board.
(3)

No person, except those licensed under subsections

(1) or (2) of this section, or any practitioner, pharmacist,

Subsection (3) of section 6
requires warehousemen, wholesalers, and any other person

or owner of a pharmacy licensed to practice or do business
in this state, shall store, possess for dispensing, or otherwise store or dispense dangerous drugs without first obtaining a license as a dispenser of dangerous drugs or clinical
researcher from the board.
(4)

All licenses issued pursuant to this section shall

be for a period of one year from the first day of July and
may be renewed for a like period annually.
X

X

........X

The annual li-

cense fee shall be one hundred dollars and shall accompany
each application for such license or renewal thereof.
(5)

The board shall specify on each such license the

limitations, if any, of the authority of the licensee thereunder.
(6)

Agents and employees of persons licensed pursuant

to this section and carriers shall not be required to obtain
a license under this section.
SECTION 7.

Qualifications for licenses.

(l) (a}

No

license shall be issued under the provisions of section 6

not enumerated in this subsection and in subsection
(6) to obtain a license as a
dispenser of dangerous drugs.
Practitioners, pharmacists,
and owners of pharmacies are
not required to obtain a license because they are controlled by the licensing board
of·their profession. Also
exempt from licensing are agents, employees, and carriers
of drugs of persons licensed
under this section or by their
professional boards.
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of this act unless the applicant therefor has furnished proof
satisfactory to the board that:
(b)

The applicant will produce, process, or manufac-

ture, or will otherwise possess or dispense any dangerous
drug in the normal course of his business; and
{c)

The applicant is equipped as to land, buildings,

and paraphernalia properly to carry on the business described in his appli~ation.
(2) (a)

Any person licensed as a clinical researcher

by the federal government shall be presumed to possess the
qualifications described in subsection (1) of this section
so long as such federal license is valid.
{b)

A clinical researcher must obtain approval of his

study, test, or experiment from the state department of
public health prior to obtaining a license from the board,
and upon obtaining such approval, the board shall issue a
license to such clinical researcher.
(3) (a)

No license shall be granted to any person

who has been convicted of a willful violation of subsections

I
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requested, or personal service setting forth the grounds by
~tatutory reference together with specific allegations of
fact for the suspension or revocation, and stating that the
revocation or suspension shall be effective twenty days
after receipt of the notice, unless prior to that time the
license holder requests a hearing.
(2)

If the license holder requests a hearing, it shall

be conducted by the board in accordance with the provisions
)(
)(

X

<

of section 3-16-4, C.R.S. 1963.
(3)

Judicial review of the board's decision may be had

pursuant to the provisions of section 3-16-5, C.R.S. 1963.

SECTION 10.

Violations - penalties.

{l)

Any person

Manufacturing or Distribution
Offenses

who . manufactures or dispenses dangerous drugs in violation

Any person convicted of unlawful manufacturing, dispensing, attempting to manufacture
or dispense, or possess with
intent to dispense, shall be
charged with a felony which is
punishable by imprisonment of
from one to fourteen years in
the state penitentiary, and
fined not more than $1,000
(subsections (1) through (3)).

of section 2 of this act shall be guilty of a felony, and,
upon conviction, shall be punished by a fine of not more
than one thousand dollars and by imprisonment in the state
penitentiary for a period of not less than one nor more
than fourteen years.

~

-------------~---~-,

(2)

Any person who attempts to manufacture or dispense

any dangerous drug in violation of aection 2 of this act
shall be guilty of a felony, and, upon conviction, shall be
punished by a fine of not more than one thousand dollars and
by imprisonment in the state penitentiary for not less than

one nor more than fourteen years.
(3)

Any person who has in his possession any dangerous

drug with the intent to dispense said drug in violation of
)C
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the provisions of section 2 of this act, shall be guilty of
a felony, and, upon conviction, shall be punished by a fine
of not more than one thousand dollars and by imprisonment

in the state penitentiary for not l••• than one nor more
than fourteen years.

(4) Any person who violates subsections (7), (8), or
(9) of section 2 of this act shall be guilty of a misdemeanor, and, upon conviction, shall be punished by a fine of
not more than five hundred dollars or by imprisonment in the
county jail for not more than one year, or by both such fine
and imprisonment.

Records - Offenses
Subsection (4) ·states that any
person can be charged with a
misdemeanor if that person
fails to keep records or
falls to obtain a license under subaection (9) of section
2.

Possession Offenses
There are three penalties for
unlawful possession of
dangerous drugs. The first
offense is a misdemeanor, and
the court may sentence the defendant to the county jail for
· not more than one year, fine
the defendant not more than
$~00,or both imprisonment and
fine.
In addition, the court can
grant probation, commit the defendant to the care and custody
of the department of institu•
tions for a period of time not
to exceed one year, or the
court may defer trial if the
defendant voluntarily commits
himself to the care and
custody of the department of
institutions. In order to
have a deferred trial both the
prosecution and defendant must
consent.

(5) (a)

Any person who possesses any dangerous drug

in violation of section 2 (5) of this act shall be guilty
of a misdemeanor, and upon a first conviction, the court may:
(b}

Impose a fine on the defendant in an amount not

to exceed five hundred dollars, or a sentence of imprisonment
in the county jail for not more than one year, or both such
fine and imprisonment;
(c)

Place the -defendant on probation for a period not

to exceed one year, and as a condition of such probation the

X
X
X
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court may require the defendant to obtain treatment and re-

....

habilitation consultation concerning dangerous drugs at a
community mental health center for such time as a psychiatrist at the center deems necessary to rehabilitate the defendant;
(d)

Commit the defendant to the custody of the depart-

ment of institutions for a period not to exceed one year,
for rehabilative treatment.
(6) {a)

At any time prior to trial for a first viola-

tion of subsection (5) of this section or to entry of a

I

The second eossession offense
is also a misdemeanor and the
court may sentence the defendant not less than one nor more
than two years in the county
jail, fine the defendant up to
$1,000, or both imprisonment
and fine.
In addition, the court may
grant probation or place the
defendant in the care and
custody of the department of
institutions for a period of
not less than one nor more than
two years.
The third possession offense
is a felony, and the court may
sentence the defendant to the
state penitentiary of from one
to fourteen years, a fine of
not less than $1,000 or more
than $2,000, or both fine and
imprisonment.
In addition, the court may
grant probation or commit the
defendant to the care and
custody of the department of
institutions for a period of
not less than one nor more
than fourteen years.
The court may also place conditions on probation which
would require the defendant
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plea of guilty to a violation of said subsection, the court
may, with the consent of the defendant and the prosecution,
order the prosecution of the offense be suspended for a
period not to exceed one year, during which time the court
may either place the defendant on probation, or, with the
consent of the defendant, commit him to the custody of the
department of institutions for rehabilative treatment.
(b)
X
X
X
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Upon satisfactory completion of and discharge from

probation or commitment to the custody of the department of
institutions, as the case may be, the charge against the
defendant shall be dismissed with prejudice; but if the
conditions of probation, or commitment to the custody of the
department of institutions, are violated, the defendant
shall be tried for the offense of which he is charged, and,
upon conviction, the court shall make disposition as provided in subsection (5) of this section.
(c)

Upon consenting to a suspension of trial as pro-

vided in paragraph (a) of this subsection (6), the defendant
shall execute a written waiver to his right to a speedy trial.

to seek treatment at a community mental health center
during the time spent on probation.
As indicated in the above
alternatives, the committee
was concerned about the possibility of a bill which could
make young people felons, particularly if they experiment
with dangerous drugs one or
two times. No public good
would be accomplished by making these adolescents felons.
The purpose of the wide latitude given to the courts is
to provide education and treatment programs for these young
people •

cp,pmn:s
(d)

If a defendant gives his consent to a deferred

prosecution under this subsection (6), it shall not be construed .as an admission of guilt, nor shall such consent be
admitted in evidence in a trial for the offense of which he
is charged.
(7) (a)

Whenever any person shall be charged with a

violation of the provisions of paragraph (5) (a) of this section, the court, prior to trial, and with the defendant's
x

><
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consent, shall cause a probation officer to conduct an investigation of the background of the defendant which shall
include, to the extent possible, but not be limited to, such
information about his characteristics and circumstances affecting his behavior as may be helpful to the court in determining whether prosecution should be deferred under subsection (6) of this section, or whether probation should be
granted if the defendant is adjudged guilty.

The court,

upon its own motion or upon petition of the probation officer,
may order any defendant who is subject to pretrial investigation to submit to a mental or physical examination, or
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both.

If a mental examination is ordered, the department of

institutions, upon request of the court or probation officer,
shall furnish such facilities and services as are necessary
to conduct such examination.
(b)

Upon completion of such pretrial investigation,

the probation officer shall submit a written report to the
court.
(c)

No substantive evidence acquired directly or indi-

rectly for the first time as the result of any such observation and examination shall be admissible on the issue of
guilt of the crime charged.
(8) (a)

A person who is convicted of a second offense

under subsection (5) of this section shall be guilty of a
misdemeanor, and upon conviction, shall be punished by:
(b)

A fine of not less than five hundred nor more

than one thousand dollars, or by imprisonment in the county
jail for not less than one nor more than two years, or by
both such fine and imprisonment; or
(c)

Commitment to the custody of the department of

DII
ln.titutiona for a period not less than one YHr nor ac,re
than two years, for rehabilative treatment; or
(d)

The court may place the defendant on probation for

a period not to exceed one year, and as a condition of such
probation the court may require the defendant to obtain
treatment and rehabilitation consultation at a comaunity
at the
mental health center for au.ch time as a psychiatrist
.
center deems necessary to rehabilitate the defendant.
(9) (a)

A person who is convicted of a third or subae-

,c

=::

quent offense under subsection (5) of this section shall be
guilty of a felony, and, upon conviction, shall be punished
by:

(b)

A fine of not leas than one thousand nor more than

two thousand dollars, or by imprisonment in the state penitentiary for not less than one nor more than fourteen years,
or by both such fine and imprisonment; or
(cl

Comi tment to the custody of the department of

institutions for a period not leas than one year nor mon
than fourteen yaara, for treatment; or
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(d}

It may place the defendant on probation for a

period not to exceed five years, and as a condition of such
probation the court may require the defendant to obtain
treatment and rehabilitation consultation at a community
mental health center for such time as a psychiatrist at
the center deems necessary to rehabilitate the defendant.
SECTION 11.

Jurisdiction.

Exclusive jurisdiction of

violations of the provisions of this act is hereby vested
x

I-"
.....

in the district courts or juvenile courts of this state.

....

SECTION 12.

Commitment to custody of the department

of institutions - special provisions.

(1) (a)

After a

person is committed to the custody of the department of institutions under the provisions of section 10 of this act,
but prior to the termination of such commitment, if the
court which committed such person receives from the department of institutions a written statement that such person
is rehabilitated and that to continue the custody of the
defendant would be of no benefit to such person, then the
court may:
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(b)

Discharge such person from the custody of the de-

partment of institutions; or
(c)

Discharge such person from the custody of the de-

partment of institutions and place him on probation for the
remainder of the period to which he was originally committed
to the custody of the department of institutions.
(2)

Except as provided in subsection (6) (b) of section

10 of this act, if any person committed to the custody of the
)(
.....
I-'•

........

department of institutions under the provisions of this act
violates any term or provision of such commitment, upon receipt of notice thereof by the court ordering such commitment, the court may revoke its order of commitment and shall
sentence the defendant to the county jail or state penitentiary for the remainder of the term of original commitment.
(3)

Any person committed to the department of institu-

tions under the provisions of this act shall have the same
right to deductions of time as provided in section 105-7-9,
C.R.S. 1963, and shall be subject to the same forfeitures
of good time as provided in section 105-7-10, C.R.S. 1963.

I
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SECTICJ4 13.

Rule• and regulations.

(1)

The board is

hereby authorized to promulgate rules and regulations to implement the prov1sioM of this act.
(2)

The state department of public health is hereby

authorized to promulgate rules and regulations regarding the
approval of studies, tests, or experiments submitted by
clinical researchers for the department's approval.
SECTI~ 14.
X
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Severability clause.

If any provision of

this act or the application thereof to any person or circumstance is held invalid, such invalidity shall not affect
other provisions or application• of the act which can be
given effect without the invalid provision or application,
and to th1$ end the provisions of this act are declared to
be aeverahle.

SECTimf 15.

Repeal.

Arlkl• 4 of Chapter 48.

c.a.s.

1963 1• zepuled.
SEC'l'mt 16.

6PP11cabi11t;J.

This act shall apply

Gilly
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Im
to violations of the provisions of the act which occur on or
after its effective date.
SECTION 17.

Safety clause.

The general assembly hereby

finds, determines, and declares that this act is necessary
for the immediate preservation of the public peace, health,
and safety.

~
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BAC<GPDUND REPORT
.
Much has been written and spoken in recent years about the use
of drugs in American society. Drug abuse has received attentlon from
the press, magazines, television, and other communication media. Research reports, numerous conferences and symposiums, and other schol•arly activities have been devoted to drug abuse problems. Legislative
attention has been given to this subject at the federal level, and by
state and local governments. Public health officials, psychologists,
psychiatrists, the police, federal officers, ,chool officials, welfare
personnel! and countless other persons have concentrated a great deal
of attent on to attempts at controlling drug use.
This report is not an attempt to cover, or even touch upon,
all aspects of the problem of narcotics and drug abuse. Instead, the
purpose of the report is to supplement with some further detail the
report and recommendations of the Criminal Code Committee with regard to the following seven specific areas: 1) the drugs which are
abused and their effects on individuals; 2) the extent of drug abuse
in Colorado; 3) the various treatment programs for drug users which
are being developed in other parts of the country; 4) information received by the committee regarding educational programs for drug control; 5) the question of whether use of "dangerous" drugs will lead
to use of narcotic drugs; 6) the relationship between drug use and
crime; and 7) additional comments by conferees during committee hearings. In addition, an appended item contains a summary df federal
laws anq laws of other states controlling drugs with a potential for
abuse •.V
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Information for this report is taken from the following sources:
The Challen e of Crime in a Free Societ, a report by the F=e ~i ent's commiss on on aw enforcement an administration of justice (Washington, D.C.: Government Printing Office), 1967,
(cited as President's Crime Commission): Task Force Report; Narcotics and Drug Abuse, annotations and consultants pape r s puS:-lished by the crime commission (cited as Task Force: Druis);
Drug Abuse: Escape to Nowhere, a guide fo~ educators (Ph Iadelphia: Smith Kline & French Laboratories) , 1967; Dru~ Abuse, 2nd
ed,, a manual for law enforcement officers, publishe by same
source; statements presenteo to the Criminal Code Committee hearings on June 2a ~and 29, July 18, and September 7; and information
presented to the Colorado Drug Abuse Institute, Vail, ColoJ'ado,
September 12 and 13, 1967, (cited as Criminal Code Committee
Memorandum No. B).

Abused Drugs and Their Effects
Four types of drugs and their effects on individuals are discussed in this portion of the report -- narcotics (opiates), depressants (sedatives), stimulants, and hallucinogens. In addition,
solvents and their effects on individuals are mentioned since sol_v ents can cause physiological and psychological effects in a manner
similar to drugs.
Narcotic Drugs
Narcotic drugs need to be defined both in medical and legal
terms. A medical definition of a narcotic is any drug that produces
sleep or stupor and, at the same time, relieves pain. Legally defined, the term means any drug regulated under the federal and state
narcotic laws, even though some of the regulated drugs are nonnarcotic by medical definition. Drugs classified medically as narcotits include: morphine and codeine (opium derivatives); heroin (a
morphine derivative); and meperidine and methadone (synthetic morphine-like drugs). All of these drugs have a potential for physical
and psychological dependence. In addition, the body will develop a
tolerance for their usage, requiring increased dosages to have the
desired effects.
Cocaine and marihuana are two drugs not considered medically
as narcotics; marlhuana has been classified a mild hallucinogen, and
cocaine ls considered a strong stimulant. However, these drugs are
included as narcotics under state narcotic laws, and federal penalties for these drugs are the same as for narcotics. (See Appendix A
for further information concerning federal law). Present medical
evidence indicates that users of these drugs probably will not become physically dependent upon either drug. However, some evidence
indicates that these drugs have a potential for creating psychological dependence.
Narcotic drugs, of course, are the most effective pain relievers known to medical science. These drugs are quite often administered by physicians to patients for short-term acute pain resulting
from surgery, fractures, and burns, or for relief of pain accompanied
with the latter stages of terminal illness such as cancer. Morphine
is a common opiate used in treating pain but many other forms of narcotics, both natural and synthetic, are used for medical purposes.
The abuse of narcotic drugs lie s in the abi li ty of these drugs
to reduce sensitivity to both psychological and physical stimuli and
to produce a sens~ of euphoria. Narcotic drugs are depressants to
the central nervous system, and these drugs can produce drowsiness,
sleep, and reduction in physical activitr• Under the influenc o of
narcotics, the addict is usually letharg c and indifferent to his environment and personal situation. Side effects can include nausea
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and vomiting, constipation, itching, flushing, constriction of the
pupils of the eyes, and respiratory depression.
When the narcotic supply is removed from the narcotic addict,
characteristic withdrawal symptoms develop, which vary according to
the degree of physical dependence. Symptoms of withdrawal from narcotics mar include: nervousness, anxiety, and sleeplessness; yawning, runn ng eyes and nose, and sweating; enlargement of the pupils,
"gooseflesh," and muscle twitching; severe aches of back and legs and
h-0t and cold flashes; vomiting and diarrhea; increased breathing rate;
elevation of blood pressure and temperature; and a feeling of desperation and an obsessional desire to secure a dose of narcotics. Th~
latter condition is known as the abstinence s,yndrome, which lasts
longer than any other symptom.
Depressants
Depressants are· any of several drugs, including barbiturates ·
which sedate the user by acting on the central nervous system. Medical uses of these drugs include: treatment of epilepsy, hig~ blood
pressure, and insomnia; use in the treatment and diagnosis of mental
disorders; and use in almost any illness or special situation which
requires sedation.
Barbiturates are reported to be the most widely used and abused
of the depressant drugs. Abuse o.f these drugs may lead to physical
and psychological dependence and a tolerance for the drug. When barbiturates are abused, the effects may include drowsiness, staggering,
and slurred speech, all of which resemble alcohol intoxication.
Other symptoms of barbiturate addiction may include sluggish reactions, erratic emotions, frequent irritability and antagonism, and
impressions of euphoria. Death can result from an unintentional
overdose of barbiturates or from mixing barbiturates with alcohol
or some other sedating drug which creates a greater effect than
either drug taken alone (potentiation). Suicidal doses may result
in a state of general anesthesia.
·
Abrupt withdrawal from barbiturates is extremely dangerous and
convulsions and dealth can result for a person who is physically addicted and has developed a high tolerance to the drug. During the
first eight to twelve hours after the last dose, the addict appears
to improve but, after this point, the following symptoms may appear:
increasing nervousness; headache; muscle twitching; tremor; weakness;
insomnia; nausea; and a sudden drop in blood pressure when the person
stands abruptly. Convulsions, which may develop after 72 hours of
withdrawal, is the characteristic which distinguishes barbituric withdrawal from narcotic withdrawal.
Stimulants
Stimulants are drugs which stimulate the central nervous systom producing excitation, alertness, and wakefulness. Caffeine, found
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in coffee, tea, cola, and other beverages, is a commonly used stimulant. Amphetamines, sometimes known as "pep pills,• of which there
are dozens on the market. were reported by the President's Crime Commission to be the most widely used and abused stimulant in the United
States. As mentioned earlier, cocaine is considered separately from
the rest of the stimulants because it is controlled under the state
and federal narcotic laws, whereas other stimulants are regulated by
dangerous drug or other drug control laws. Cocaine was once widely
· used as a local anesthetic, but this use of cocaine has been sup~
planted by less toxic drugs. Cocaine reportedly is not abused to a
great extent.
Stimulants are used medically for treating narcolepsy (a·disease characterized by involuntary attacks of sleep); counteracting
the drowsiness caused by sedative drugs; aiding in weight reduction:
and relieving mild depression. The latter two uses are the main
medical uses for stimulants. Stimulants may produce a temporary
rise in blood pressure, palpitations, dry mouth, sweating, headache,
diarrhea, pallor, and dilation of the pupils. Such effects are generally seen only with high doses or as side effects with therapeutic
doses. Stimulant drugs, excluding cocaine, seldom cause death, even
in acute overdosage. However, delusions or hallucinations may result
from too large a dose or too sudden an increase in dosage.
Stimulants are abused because they elevate the mood of the
user and create a sense of well-being. Most medical authorities are
reported to agree that stimulants do not create a physical dependence, and there are no physical withdrawal symptoms. Psychological
dependence does develop, and mental depre·ssion and fatigue are quite
common after the use of stimulants is discontinued. Psychological
dependence is an important factor in users• continuance of and relapse to continued stimulant drug abuse. Tolerance also develops in
use of these drugs. srmptoms of abuse include talkativeness, excitability, restlessness, nsomnia, profuse sweating, urinary frequency,
and a tremor of the hands.
Hallucinogens
Hallucinogenic or psrchedelic drugs are a very broad group of
drugs which distort percept ons by creating dream images and hallucinations. To date, medical uses for hallucinogenic drugs have not
been definitely established. Legal possession of hallucinogens is
strictly controlled by the federal government. The most widely known
of these drugs include DMT (dimethyltryptamine); LSD (lysergic acid
diethylamide); mescaline and its salts; and peyote. Provisions of
the federal law do not apply to peyote use in bona fide religious
ceremonies of the Native American Church. LSD is considered one of
the most potent of the hallucinogenic drugs and peyote and mescaline
are considered moderatelI potent. Marihuana was mentioned earlier as
being classified medical y as a mild hallucinogen.
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The general effects of hallucinogenic or psychedelic drugs
are fairly widely known due to the large measure of interest by the
public and coverage by the newa media of the "hippie" movement and
to an apparent increase in the use of mind altering drugs by several
segments of society. Although hallucinogtnic d:rugs have varying degrees of effects which last for varring lengths of time, users have
reported numerous reactions to LSD ncludlngc visual distortion• of
.1hape1 and human forms; sharpening of all senses; bright, vivid hallucinations; and depersonalization or loss of ego identity.
The Medical Society of the County of New York cited the following dangers of LSD uses prolonged paychosia; acting out of character dl1order1 and homosexual impulses! suicidal inclinations;
activation of previously latent psychos a; and reappearances of the
drug'• effects weeks or even lllOnths after use. Corresponding with
dangers the same source reported that the LSD user " ••• is·enveloped by a sense of isolation and ia often domtnated by feelings of
paranoia and fear. If large doses are ingested over 700 mcg.) confusion and delirium frequently ensue. During LSD use, repressed
materlal_~ay be unmasked which is diffucult for the individual to .
handle."V In addition Dr. Blum told the committee that studies conducted by the National institute of Mental Health have concluded that
chromos2~e damage has oc.eurred in &ub-human animals given large doses
of LSD.~ Because of extreme effects which these drugs may have,
authorities are in agreement that hallucinogenic drugs should not be
administered other than in a supervised clinical research atmosphere.

th•••

l•rihuana

This drug is discussed separately from the other major categories of drugs because of its special characteristics which make it
difficult to categorize as a narcotic, depressant, stimulant, or hallucinogen. The federal government and all of the states list the
drug a narcotic drug but the Medical Society of the County of New
York reported that the drug is a mild hallucinogen. The President's
Crime Commission said that the effects of the drug are rather complicated, combining both stimulation and depression, with much of the
drug's effect depending upon the personality of the user.Y
Marihuana is generally smoked, but the drug can be sniffed or
ingested. The mental effects of the drug may include a feeling of
euphoria, exaltation, a dreamy sensation accompanied by a free flow
of ideas, and a distortion of the sense of time, distance, vision,
and hearing. Side effects which may accompany these effects include

res dent's r me Commission, p. 215.
Criminal Code Commlttee Minutes, July 18, 1967, p. 5.
President's Crime Commission, p. 213.
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dizziness! dry mouth, dilated pupils and burning eyes, urinary frequency, d arrhea, nausea, and vomiting, and hunger, particularlr for
sweets. Much of the effect of the drug depends on the personalty
of the user.
Medical science has concluded that marihuana does not produce
physical dependence and there are no withdrawal symptoms. The use
.of marihuana may result in a slight psychological dependence in soMe
individuals. Researchers have compared the effects of marihuana on
an individual as being similar to the effects of a moderate amount
of alcohol (also a drug); and, as far as is known, there are few detrimental physical effects on the user.
Since there has been considerable controversy recently concerning the dangers inherent in the use of marihuana, it may be of
interest to report on statements presented in meetings of the Criminal Code Committee on this subject. No one who met with the committee advocated the "legalizing" of marihuana in the sense of the state
sanctioning its use by removal of all penalties relating to this drug.
The committee report pointed out that marihuana is still controlled
br the federal law and state statutes could not be in direct contrad ction of the federal statutes concerning marihuana. Further, research at the federal level is reportedly in progress to determine
more fully the dangers inherent in this drug. This research will'
undoubtedly take some years to complete.
In view of the lack of research concerning marihuana, it is
difficult to state what dangers to society could exist if this drug,
or other drugs, were legalized. Dr. Richard H. Blum, director of the
psycho-pharmacology project at Stanford University, told the Criminal
Code Committee that Morocco is one country where marihuana is legally
available; consequently, the drug is found in a much stronger form
than in the United States. It was reported that 18 percent of the
marihuana users in tb~t country are likely to be hospitalized for
marihuana psychosis.~ Further discussion of the varified risks and
reported risks of marihuana is contained in the crime commission Task·
Force Report: Drugs, pages 24 and 25.
·
Solvents
The abuse of solvents or "volatile intoxicants" is usually by
inhalation or sniffing of fumes to produce a form of intoxication.
Substances abused in this manner include, among other materials,
glue, gasoline, paint thinne·r, lighter fluid, and ether. Chief dangers of inhaling or sniffing these substances are the possibility of
death by suffocation, the development of psychotic behavior, and the
state of intoxication which these substances produce. It is also reported that physical damage to certain body or9ans and to the nervous

i/
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system is. a distinct possibility since many solvents and the ingre-_.
die.,nts of L ,ome types of glue can cause physical damage if taken in- •·
ternally.w
.
The consultants to the President's Crime Commission cited two
reasons for concern in the id~ntification of sniffers: 1) to preven\
danger while they are intoxicated; and 2) to forestall. the otherwise
very likely development of later dependency on other drugs and presumed criminal associations possibly arising out of interest in
illicit drugs. Two recommendations were submitted by the consultants
in regard to the identification of sniffers. First would be to encourage school and public health persons to develop new methods for
case finding for children engaged in this activity and, secondly,
that each school, health, and police agency participate in a community-wid~1program for the referral of such children to psychiatric
treatment .11Narcotics and Drug Abuse In Colorado
It is impossible to assess the extent of use of narcotics and
dangerous drugs in Colorado on the basis of objective statistical
data. Newspapers, television, and other public media may provide
some subjective means of measuring the extent of drug abuse, by at
least indicating through the volume of articles that the drug problem in Colorado is not insignificant and that the public is interested in this subject. However, reliable, verifiable statistics on
the number of drug users, the types and amounts of drugs used, and
the groups of persons using drugs are simply not available.·
Statistics from police departments on the number of drug abuse
arrests may indicate a tremendous percentage increase in police activity in drug control in recent years. Such data, however, may be
indicative of increased police attention to problems relating to drug
abuse. An increase in percentages may result, in part, from an extremely low base figure in previous years so that even a few arrests
for drug abuse would account for a large percentage increase. It is
possible that, in the case of dangerous drugs, both the most vigorous
advocates and opponents of drug use tend to exaggerate the extent of
drug abuse in attempting to prove the validity of their positions
toward legislation concerning drug use.
Information received from the regional office of the Federal
Bureau of Drug Abuse Control, in operation in Denver since mid-1966,
reported 20 investigations opened for the period of July through
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September, 1966, while for the same period of 1967, 80 investigations
were opened on violations of federal dangerous drug laws. No convictions for illegal sale of dangerous drugs were obtained on investigations conducted by the regional office in 1966, but 18 convictions
for illegal sale of dangerous drugs were recorded from January through
September of this year. These convictions were only for illegal sale
of dangerous drugs and do not include any possession cases, which is
.not an offense under federal statutes.
The preceding comments, however, are not intended to dismiss
the seriousness of drug abuse in Colorado. It is obvious from the
public media that drugs are being abused and that many segments of
the public are concerned with problems attendant with drug use. Even
though complete data, or even reliable estimates, are not available
on drug use, some generalizations may be made concerning narcotic and
dangerous drug abuse throughout the United States and in Colorado.
Narcotics. Taking first the problems of narcotic drugs, this
area of drug use does not appear to be as severe as the dangerous
drug problem in Colorado, at least in terms of numbers of users. In
recent years, the real and absolute numbers of known narcotic addicts
in Colorado has declined slightly, with the known number of narcotic
addicts in the state now at 305. However, not all addicts are known
addicts and it is necessary to multiply the known number by a number
of from three to ten as an estimate of the actual number. Using
these figures, the total narcotic addict population would vary between approximately 900 and 3,050 addicts.
The President's Crime Commission reported that more than onehalf of the known heroin addicts in the United States are in New York
and most of the others are in California, Illinois, Michigan, New
Jersey, Maryland, Pennsylvania, Texas, and the District of Columbia.
The report stated that, where heroin addiction exists on a large
scale, it is an urban problem, found largely in areas with low average incomes, poor housing, and high delinquency. The heroin addict
was said likely to be male, between the ages of 21 and 30, poorlr
educated a1_1q unskilled, and a member of a dlsadvantaged ethnic m nority group.§/
Hallucinogens. One of the consultant's papers published in
Task Force: Drugs reported that the use of hallucinogenic drugs in
this country appears to be concentrated in young adults age 20 to 25,
but there are signs of rather rapid diffusion to high school age
levels and, less rapidly, to middle and older aged adults. ·The same
authors stated that it would be unwise to venture anI estimate of the
number of Americans who have tried one or another ha lucinogen; any
numerical estimates must be suspect. In view of the lack of information to the contrary, the following quotation from these consultants
to the President's Crime Commission, Ythlch concerns the characteris-
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tics of LSD users in the United States in general, might be applicable to Colorado:
Until a few years ago, LSD remained limited
to an "elite" group of successful professionals,
artists, and comrnuni.cations industry personnel,
their families and friends. These same groups
still appear to be using hallucinogens, but the
concentration of use appears to have shifted to
younger persons. Among teenagers·, motorcycle club
members, delinquents, urban poor and minorities,
etc., there are reports of spreading interest, suggesting the exp.ected diffusion down the socioeconomic scale. No common psychological or sociological
features may be expected among the users of any
secular and social drug; different people take drugs
for different reasons. Within groups sharing common
sociological characteristics it is sometimes possible to differentiate drug-interested persons,
regular users, heavy users, etc., on tb~ basis of
psychological or background factors ••• .21
Stimulants, particularly amphetamines, may be subject to abuse
or non-supervised medical use by persons s.eeking to combat lethargy,
overweight, and fatigue. Students studying for exams, truck drivers,
and night shift workers have been cited as groups using amphetamines.
Social and private use has also been reported for persons seeking
excitement or mood changes in the sense of "kicks" or "highs". The
consultants to the Crime Commission reported that various studies
have identified use among late adolescents, including delinquents,
but extending to others described as "rebellious," "wild," or simply
"party going." Some data was reported to support the view that amphetamine abusers and those prone to dependency were badlr adjusted
youngsters before using these drugs.!Q/ A major concern n the control of stimulant drugs is the vast quantities produced (4~ billion
tablets in 1962) of which a large percentage,_perhaps one-half of the
total, is estimated to go into illicit distribution channels.
Barbiturates. As in the case of stimulants, there is little
information about which people use barbiturates and how often drugs
in this classification are used. The extent of abuse of barbiturates
is difficult to assess, especially since case finding procedures are
subject to error. One example cited of the problem of identifying
drug abuse, including barbiturates, was in a Boston hospital in which
only six of 82 cases of drug abusers had been officially reported to
an agency.11/
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(Paper by Blum and Funkhouser -

In summary, it appears that a changing pattern of drug abuse
has been evolving in recent years. A large segment of narcotic drug
abuse historically has been found in ghettos or poverty areas of
the largest cities in the country. Reasons for this phenomenon are
many, but one important factor is that the use of narcotic drugs
represents to the user a form of escape from the realities of a poor
environment., However, it should be noted that drug abuse occurs in
all social and economic classes and persons who can purchase their
drugs without resorting to crime or can afford private treatment are
less lik~A~ to become a part of police records and drug abuse statistics.~
Dangerous drug abuse, rather than narcotic addiction, is
often found in the middle- and upper-economic levels of society.
Perhaps it is because drug problems are no longer limited to certain geographic areas or to the lower-economic levels, society as a
whole has become more concerned with problems of drug abuse. Abuse
of dangerous drugs is said to have a growth pattern starting in older generations and moving down to younger persons, which pattern is
the reverse of the narcotic addiction pattern. A number of persons
have said, for example, that abuse of hallucinogenic drugs started
with college professors and spread to graduate students, then toy~,
dergraduates, high school students, and even to younger students.~
Professor Blum told the Committee that the group of LSD users is becoming younger, even to the extent of e ~entary school children in
California experimenting with the drug •.:!:!V Corresponding with the
shifting pattern of drug abuse to include middle- and upper-economic
and social levels of society, Professor Blum stated that the younger
generation's drug abuse has shifted away from alcohol, narcotics,
and other toxic substances to more sophisticateg_qrugs, including
LSD, marihuana, and other exotic hallucinogens.12/
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It is also pointed out that young people are not the only
drug abusers as many respectable adults in all occupations abuse
drugs. For example, physicians and others who have irregular sleeping habits and need to sleep immediately after lying down, may have
a tendency to abuse depressant drugs. Drug abuse by young persons
may be in the form of experimentation and by persons who want to explore life of which drug use is just one aspect. Seldom do young
people continue drug abuse. Adolescents who continue using hallucinogenic 9f~gs are said to do so because of some deep-rooted emotional
problem.!21
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Drug Treatment Programs
When considering the development of treatment programs for
drug abusers and addicts, the distit;1ctions between "dangerous drugs"
-- hallucinogens, stimulants, and depressants -- and "hard narcotics" become somewhat complicated. For example! use of practically
.any drug or substance can create a psychologica dependence for the
user, but a physical dependence is generally consideted to develop
only in use of narcotics and depressants. However, the committee
was told that psychological dependence was much more difficult to
cure than was physical withdrawal. Further, physical withdrawal from
barbiturates and other sedatives (depressant drugs) pose serious difficulties which can require more intensive medical supervision than
does withdrawal from opiates. Deaths can occur if dependence tp
these drugs is not detected and convulsions and delirium occur •.!1/
In short, it appears that a variety of treatment approaches
and facilities would be required to handle the different types of
drug abusers. Chronic abusers of hallucinogens, stimulants, or solvents might need to be treated for emotional or psychological problems rather than physical withdrawal. Abusers of depressant drugs
appear to need trained personnel and intensive care facilities during
the withdrawal stage from drugs followed by psychological counseling
programs. A program for narcotic addicts, in order to have a chance
for 5uccess, requires withdrawal facilities, psychiatric services,
and aftercare programs to assist in the addicts' return to the community.
Policy questions concerning treatment programs which need to
be answered include whether a treatment program is needed for users
of all drugs, including hard narcotics and the dangerous drugs, or
should attention be focused on treatment programs for selected
drugs? Does the number of narcotic drug users in Colorado warrant
the development of a treatment center by the state? If persons use
some of the non-narcotic drugs on themselves, without noticeable
harm to society, should the state use its resources for a problem
which mar be considered more troublesome by the general public than
it actua ly is, medically speaking?
As far specific needs for treatment facilities in Colorado,
the following excerpt of the statement presented to the committee by
Dr. Hans Schapire, Chief of Psychiatric Services of the Colorado Department of Institutions, represents the viewpoint of one person who
is familiar with the state's existing facilities and with probable
future needs for a narcotic treatment program:
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o.

Cole,

As you undoubtedly know, the two federal
narcotic hospitals at Lexington, Kentucky,and
Fort Worth, Texas,are in the process of being
converted into pure research facilities. This
means that narcotic addicts from the various
states will no longer be able to receive treatment in these two facilities which have been
placed under the jurisdiction of the National
Institute of Mental Health. The intent of Congress as spelled out in the Narcotic Addiction
Rehabilitation Act of 1966 (Public Law 89-793)
is the provision of treatment and rehabilitation
facilities for the narcotic addict in his own
state or community. For this purpose, the Surgeon General has been authorized to make such
contractual arrangements as may be necessary
with private and public facilities to provide
examination and treatment for persons falling
under the provisions of this act. It seems
therefore highly desirable that both the State
Hospital and the Fort Logan Mental Health Center be prepared to treat addiction and habituation so that the most appropriate treatment for
the individual be available both on an inpatient
and ambulatory basis. As far as Colorado State
Hospital is concerned it has now in operation an
alcoholic treatment and addiction center housing
about 70 patients. The overwhelming majority of
these persons are alcoholics. It would not be
too difficult to expand existing services and to
provide more specialized services for those narcotic addicts who will require care no longer
available in the Federal centers. However, 60%
of the known addicts in Colorado {total number
200) live in the Denver metropolitan area. I
therefore recommend that a specialized treatment
unit be developed at the Fort Logan Mental Health
Center, staffed by those interested and skilled
in the treatment of drug dependence. This new
unit should probably be a part of a new division
which would include the present alcoholism unit.
A careful study would have to be undertaken to
determine what, if any, additional construction
will be required. However, legislative intent
and concern should be expressed by making planning funds available to the Department of Institutions in the next session of the General
Assembly.
Even the most modern treatment facility and
the most dedicated staff will have poor results
unless provisions are made to carry the rehabilitation of the narcotic addict into the community.
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It might be wise in the course of.funded planning to learn more about the operations and
experiences of the California rehabilitation·
center, the program of the State of New York,
and about certain.J:)f.}W methods of treatment of
narcotic addicts.!!!/
It will be noted that practically all of the treatment programs concern treatment for narcotic addicts, particularly for heroin users. Estimates of Colorado narcotic addicts vary between 900
and 3,000 persons. A more serious problem, in the number of abusers,
probably exists in regard to dangerous drug users.
·
For drugs which are physically addicting, reports indicate
.that some experimental programs have been more successful than previous programs, which have detoxified the addictt but returned him
to his old environment. Generally, more successtul treatment programs consist of controlled withdrawal in a hospital setting, rehabilitation programs, and aftercare treatment. The basic elements
of a program developed by the Boston state hospital may be of interest in illustrating one program developfg,for narcotic and barbituric drug users by a state institution.!zt
It is interesting to note that most of the patients admitted
to this program were said to have severe character disorders for
which they need assistance nearly as much as for their drug addiction problem. Prior to their admittance to the program, the patients
were reported to have averaged three arrests, usually for crimes committed to procure drugs. The patients represented a wide variety of
work experiences but are below average in work skills and abilities.
The educational level of the addicts was said to range widely, with
as low as the third grade level and a median at the tenth grade
level.
When the addict is first admitted, he is examined physically,
and a drug withdrawal program is initiated. If the addict uses narcotics, methadone, a synthetic narcotic drug, is used for about four
weeks in decreasing quantities during withdrawal. If the addict has
a barbital dependence, nembutal is administered in decreasing quantities during withdrawal, for approximately six weeks. If after a
reasonable length of time an addict cannot be withdrawn under this
treatment method, he is referred elsewhere.
Use of drugs during the withdrawal phase was described as an
adjunct to other forms of treatment. For example, during and after
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withdrawal, the addict begins to develop a few basic work habits by
assignment to the shop area. An addict may feel depressed and there
may be a considerable disparity between his aspirations and his actual work level.
After withdrawal is completed, the patient is given a series
of tests to determine whether he should return to school for further
education or should be sent directly into the job placement program.
The treatment program maintains a job placement file and jobs are
found for the addict. The center tries to scale the addict's employment to realistic work standards that off er reaso'nable chances
of success. At this point in the program the hospital ward becomes
a half-way house with the addict going to school or his job during
the day, and returning to the ward at night. Group therapy sessions
are held in the evenings in which the addicts can discuss problems.
These group therapy sessions were said to provide a safety valve for
release of the addict's daily problems.
When the addict is fully employed and has developed some
basic work habits, he is released to an out-patient status and the
aftercare program begins. The aftercare program is concerned with
physical and mental problems and consists of frequent visit~, health
care, and readjustm~nt to family life and society. Studies have
concluded that a drug addict abuses his health and continues to neglect his health for a long period of time after withdrawal. The
family life generally lacks love and other family problems may be
present. Frequently, the spouse of the ex-addict treats him as if
he was still addicted to drugs. The program provides family relation services and may bring in other social agencies in an attempt
to bring the family closer together. If at any time there is evidence that the ex-addict is using drugs, he is readmitted to the
ward.
Several other experimental programs have been initiated in
an effort to find better or more permanent treatment progr~ro~ for
drug abusers. Some of these programs are mentioned below.~
(1) Methadone maintenance is a program of substituting methadone for heroin. The program was started in New York by Drs. Vincent
P. Dole and Marie Nyswander. In this program the addict is withdrawn
from heroin and gradually methadone is administered until a daily
dose is stabilized. The effect of methadone is to block the euphoric
effects of heroin and methadone does not produce euphoria sedation or
distortion of behavior. The addict returns daily to the clinic for a
dose of methadone. Tests are made for the presence of heroint and if
a test is positive (i.e., heroin found in the addict's system,, he is
removed from the program. No meaningful conclusions have been made
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from the prog~am because of the newness of the program. Patients
in the hospital ln which this program has been used and school dropouts in slum areas are said to be enthusiastic about the possibilities of this approach. The crime commission reported that the
results of research on this subject are fragmentary and final judgments on its suitability are not yet possible.
(2) Ha\fwa~ Houses. Several communities have established
·helfway houses. Te houses frequently will have ex-addicts on the
sta·f.·f .for liaison and orderly duties. Group therapy and guidance
will be major functions of the house. An attempt will be made to
change the addict's environment. No pressure is made to have the
addict obtain a job immediately upon joining the house, although
the persons in the house are expected to assume responsibilities
for the house while living there.
.
(3) Hai~ht-Ashbur Medical Clinic was recently established
by th~ Universl y of Call ornla Medical School. The clinic is open
to treat any hippie who wants medical treatment for social and other
diseases as well as for "bad trips" on LSD. This program is too new
to formulate any conclusions concerning appropriate treatment for
LSD users. However, one consultant to the President's Crime Commission indicated that abusers of LSD and other hallucinogena who
develop psychiatric symptoms .(sc.hizophrenic-like or panic reactions)
can probably be adequately handled in conventional psychiatric setting!$.

1

(4) Community Addiction Centers have been established in
store fronts In a few large cities. One major purpose of these
centers is to dispel the commonly held belief that drug addicts
cannot be treated. Ex-addicts have been working in these centers
and block workers, including VISTA members apd local residents, cooperate in educational programs concerning drugs for the particular
block or area.
·
As for treatment for abusers of stimulant and depressant
drugs, it has been suggested that some combination of intensive
supervision and treatment plus regular monitoring to detect relapse
might be useful. However, the same source stated .that more study
of the groups abusing these drugs is needed urgently as a basis for
clearer recommendations. It will be recalled that withdrawal from
depressants may require more intensive medical supervision than does
withdrawal from "hard" narcotics. Thus, some specialized training
may be necessary for personnel in institutions which might handle
cases of depressant drug abuse.
It should be pointed out that in treatment programs developed
thus far for depressant drug abusers, the prognosis for cure of
physical dependence is poor, and the problems presented are reported
to be similar to problems encountered in the treatment of opiate addicts. However, a strong argument can be made for an effort in the
direction of treatment programs rather than taking a punitive approach toward these drugs. One of the ~onsultants of the crime com-
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mission report compared a punitive approach for depressants with the
futility of that approach for alcoholic and narcotic addicts.
While little is known about punitive approach toward users of "medical depressant or
stimulant drugs," it may be expected that as in
the case of alcoholics and narcotic addicts a
punitive approach to users who have lost control
over their use will result in a "revolving door"
or a repetitive cycle of arrest, release and
arrest, or arrest, conviction, imprisonment, release and arrest. In neither the case of the
alcoholics nor narcotic addicts has it been
shown that such a process aids the user to abandon his habit. The only thing that such a
process accomplishes is to keep dependent users
off the streets for some period of time. In the
case of alcoholism it has been referred to as
"life imprisonment on the installment plan." If
the sole object of this process is to keep dependent users off the streets, the object could
be better accomplished either by longer prison
terms or by long periods of nonpunitive isolation
from society.
Isolation would be based on the view that
addicts and habitual users commit crimes and
sell drugs to support their habits, or for other
reasons, and introduce nonaddicts to drugs.
This view has been advanced to support long periods of isolation for narcotics and addicts irrespective of whether a particular addict has
committed a crime other than possession or use •••
The known facts certainly do not warrant it in
the case of addicts and habitual users of "medically depressant and stimulant drugs •••• "
If it is feared that dangerous drug abusers
will introduce nonusers to drugs and distribute
drugs, they may be punished for trafficking
offenses including possession for the purpose of
sale or distribution. If it is feared that use
will lead to crime, the user may, unless he
should be determined irresponsible, be punished
for the crimes he commits. If particular
abusers are dangerous to themselves or others
because of mental illness or otherwise meet
general requirements for hospitalization of the
mentally ill, they should be treated as other
mentally ill persons and isolated for the safety
of society and of themselves and for any possible treatment that may be afforded to them.
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If they only possess or use drugs and are not
sufficiently disturbed by their use to meet usual standards for commitment as mentally ill,
or as long as there is little likelihood that
they can be successfully treated, they should
not be subjected to nonpunitive isolation •••l!/
Drug Education Program§
Several criticisms of present drug education programs were
mentioned to the Criminal Code Committee. The educational issues
raised might best be summarized in the questions: Who needs to be
educated in regard to drug abuse? How can the most beneficial educational programs be developed?
Professor Blum and several other conferees told the committee
that, in general, the best approach to the drug abuse problem wtls
through education. It is necessary to teach youths that, if it is
necessary to explore, it is important to have the proper education
to explore. Attitudes toward drugs should be formed early, beginning in the elementary schools. Parents should begin teaching
children informally the dangers of drug abuse. Dr. Blum said that
adolescents should have a basic grounding of drug education by age
fourteen.
An educational approach toward drugs requires that teachers
be well educated on drug problems before they begin to teach students. One problem mentioned in regard to some educational ·programs
was that the students will known more about drugs than do the teachers. The crime commission verified previous conclusions that public
and professional education in the field was inadequate and was
"clouded by misconceptions and distorted by persistent fallacies."
Professor Blum stated that many educational attempts were archaic
with the proper methods and aids simply not available to teachers.
It was also noted by Dr. Blum that parents, the police, and
medical doctors need to be included in the drug education program
since these persons are in a position of influencing patterns of
drug use in the society. One specific suggestion was that state
funds be made available~iq educate law enforcement officers in drug
abuse and drug control.~
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A staff member of the state department of public health suggested that an educational program include the teaching of safe use
of prescribed drugs which are used in every day medicine, many of
which are extremely potent. This topic should be interwoven into
the health curriculum of the schools so that future citizens have a
complete understanding of both the dangers and benefits of modern
drugs. It was reported that the Colorado Public Health Association
is develgp~ng a project to formulate curriculum material on this
subject.W
The possibility of children experimenting with drugs at an
earlier age, because of their knowing about drugs, was acknowledged
by Dr. Blum as a possible danger of a drug education program. However, this remark was qualified by the statement that children are
going to hear about dangerous drugs sooner or later, and it will be
better for the children to have a well-rounded drug education which
would provide an intelligent choice on whether to experiment with
dangerous drugs. If the children are inclined to experiment, at
lea~t th?Y w~!l have knowledge of the drugs with which they are experimenting.~
It may be easier to cite the need for increased educa.tional
efforts in regard to drug abuse than it is to present a workable
program tnrough which young persons can be accurately and adequately
informed on the dangers of drug abuse. A sound drug education for
teachers in elementary grades, as well as in junior high and high
schools, appears to be one of the first necessary steps. Use of
technically qualified professional persons, including medical doctors and pharmacists, by the schools in developing drug educational
programs could be highly significant. Some educational materials
can be obtained from pharmaceutical manufacturers, federal offices,
and from film libraries. In view of criticisms discussed earlier
of some of the teaching materials that are being used, it is important to carefully evaluate the drug education information being
presented in the schools.
The Question of Dangerous Drugs
Progressing to Use of Narcotic Drugs
Another consideration to be noted concerns the possible progression of drug use from dangerous drugs to hard narcotics. There
are some popular beliefs that a correlation exists between marihuana
use and later addiction to heroin. Similar beliefs might be held in
regard to use of other dangerous drugs and the future use of "hard"
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narcotics. Dr. Blum reported to the President'e Crime Commission
that"The evidenc& from college students and utopiate and news articles is clear that many persons not in heroln•risk neighborhoods,~~<}
experiment with marihuana do not 'progress' to 'hard' narcotica."~
In another paper to the Commission Dr. Blum stated:
Most persons who experiment with marihuana do
not try heroin, some heroin users •• •even in .
slum cultures ••• have not first tried marih'uana,
and among heroin users first trying marihuana
a number of other common factors are also
likely to be present. Among these may be experimentation with other· illicit drugs reflecting a general,Battern of drug interest and
availability.l2/
·
Dr. Alan Frank, a psychiatrist at the UniverEitr of Colorado
Student Health Services, in speaking of LSD use, expla ned that cer•
tain people need a crutch throughout life and will search until they
find their crutch. Drugs, to many persons, represent a crutth. If
one of the milder drugs does not give the desired effect, an indlviduat.,ill search for a stronger drug to obtain the necessary support.~ Taking this view, it could be concluded that the p~~sonality
makeup of these persons, rather than the use of milder drugs, could
push these persons into the use of narcotics.
Dr. Blum also stated to the committee that the best theory on
drug addiction assumes that a certain pre-mental pattern must be present before a person will become addicted to drugs. Also, the use
of drugs over a long period of time was said to increase tha chances
for drug addiction. This latter theorr on drugs was eompared
a
similar pattern found in use of alcoho leading to alcohol1$m.i£'

~Bth

Drµg Use and C:rime
Another important question on which there has been considerable
discussion over a long period of time concerns the possible correlation between drug use and crime. The President's Crime Commission
and the consultant's papers provided considerable discussion to the
question of a possible relationship between drug abuse and crime. ·
This subject is complicated by a lack of adeqUate evidence! particularly in regard to use of marihuana end crime. Any rel1t1onship
between crimes and drugs appears to depend upon such factors as the
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personality of the individual using the drug, the drug being used,
· and the person's style of life before and after using the drugs. In
discussions of this topic it is advisable to consider the users of
hard narcotics separately from the users of certain dangerous drugs.
Two reasons were pointed out whereby persons who are addicted
to hard narcotics are not able to maintain their addiction without
running afoul of the criminal law. First, an addict has a constant
need for drugs which must be purchased and possessed before they
can be consumed. Purchase, possession, and sale of opiates, in general, are criminal offenses under state and federal laws. The commission also noted that many states have prohibitions against the
possession of paraphernalia, such as needles and syringes, designed
for use by narcotic addicts. Thus, the commission concluded, the
narcotic addict lives in almost perpetual violation of one or several criminal laws which pertain directly to the use of drugs.
The second conflicting area concerns offenses of the fundraising variety. Assaultive or violent acts, contrary to popular
belief, were said to be the exception rather than the rule for the
heroin addict, since the drug has a calming and depressant effect.
However, in order to support the narcotic habit, the addict must
usually turn to crime, particularly the theft of property.
The following statistics used by the President's Crime Commission were supplied by the Federal Bureau of Investigation. A total
of 4,385 people identified as heroin users had an average criminal
career (the span of years between the first arrest and last arrest)
of twelve years during which they had averaged ten arrests. Six of
these arrests, on an average, were for offenses other than narcotics.12/ Dr. Blum pointed out to the committee that many narcotic
addicts had criminal records before they became addicted to narcotics. They show trends of continued use of narcotics and they will
also continue criminal activities.~
In regard to a correlation between crime and violence and
use of marihuana, the President's Crime Commission said that differences of opinion are absolute and the claims are beyond reconciliation. One view is that marihuana is a major cause of crime and
violence and another is that marihuana has no association with crime
and only a marginal relation to violence. In essence, the Commission reported that neither side could prove their case based on
present evidence but suggested the following hypothesis in regard
to crime and violence occurring with the use of marihuana:
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One likely hypothesis is that. given the
accepted tendency of marihuana to release inhibitions, the effect of the drug will depend
on the individual and the circumstances. It
might, but certainly will not necessarily or
inevitably, lead to aggressive behavior or
crime. The response will depend more on the
individual than the drug. This hypothesis is
consistent with the eviden~e that marihuana
d~es not alter the basic personality structure.W
In discussing drug use and. crime with the committee, Dr. Blum
mentioned that the hallucinogens may cause the user to engage in
some bizarre acts and also have caused some suicides. Statistics on
amphetamine use were said to show no causal relationship between the
drug and crime. Cocaine was reported to show some evidence of causing agitation, but the direct relationship of the drug to crime was
remote. It is interesting to note that Dr. Blum said that one known
causal relationship between drug use and crime was with alcohol.
Crimes committed under the influence of alcohol were described as
crimes of violence, although studies on this subject have shown that
the person committing such an act and the person against whom the
act was c~~itted have had previous histories of committing acts of
violence.~
Possibly the best summary of the question of a relationship
of drug use to crime is the following quotation from Dr. Blum in a
paper to the President's Crime Commission:
••• LI7he.best evidence to date suggest that
the drug-crime relationship depends upon the
kinds of persons who choose to use drugs, the
kinds of persons one meets as a drug user, and
on the life circumstances both before drug use
and those developing afterward by virtue of the
individual's own (e.q., dependent or addictive)
response and societyis response to him (prohibition of use, arrest, and incarceration, etc.).
In spite of popular beliefs.to the contrary, one
dare not assume that drug-dependency qua dependency leads inevitably to any particular type ~f
social conduct, including criminality. Insofar
as some activities are part of obtaining and using the drugs themselves, these will be repeated
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but these activities may or may not be criminal
depending, as we have noted, on the laws and
social circumstance of the person.W
Additional Statement§ to the Committee
In addition to the material previously included in the Committee Report and Recommendations and in the Background Report, a
number of other statements were submitted and considerable discussion was held with the conferees who met with the committee on June
28 and 29, July 18, and September 7. Copies of the complete statements and the discussions with these conferees are available in the
committee minutes. However, in order to provide a more complete
picture of the variety of points of view expressed in these hearings
and to mention some additional issues presented to the committee, a
brief outline of the statements of four conferees is presented below.

Mr. John Gra Detective Intelli ence and Narcotics Bureau
Denver Po ce Department.
De ec ve rays pos tion,on angerous drugs was to favor stringent legislation controlling all'dangerous drugs because the drug abuse problem in Colorado has grown to
large proportions in recent years. The problem was due primarily to
an influx of "hippie type subcultures.• This influx is due to a
lack of state legislation controlling dangerous drugs. Strong lawa
concerning dangerous drugs would discourage hippies from coming to
Colorado for they would know they would be dealt with firmly if they
did enter the atate. .
For adequate control of the drug abuse problem, the police
departments in Colorado need strong penalties for unlawful possession and use of the dangerous drugs. It is difficult and expensive
to control dangerous drug abuse without possession penalties because
of the difficulty of proving unlawful sale. Undercover agents buying unlawfully possessed drugs must be specially trained, and they
can be used as an undercover agent only once in any one area. With
strong possession and use penalties, it would be unnecessary to
prove unlawful sale, and undercover agents would not have to be
used. Detective Gray said that a weakness of the federal law is
that it fails to make possession and use of dangerous drugs illegal.

@ Task Force: Drugs, p. 23. (Paper by Blum and Funkhouser Balbaky).
W Criminal Code Committee Minutes, June 28 and 29, 1967, pp.
42 - 46.
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Mr. Lester Thomas, Denver Juvenile Court.~ Mr. Thomas has
worked primarily In the area of solvent abuse. He was opposed to
any state legislation which would make solvent abuse a crime and
suggested two reasons why solvent abuse should not be a crime.
First, any attempt to control all solvents would fail because of the
wide use of solvents which can be abused.
Second, the only solvent abuser who would be prosecuted would
be those children who are from the lower income families who have
serious family, economic, and social problems with which they must
cope. Making these children delinquents or attaching a stigma of
glue sniffer would only cause greater problems for the child. Mr.
Thomas said that children who sniffed glue alone, away from his
peers, needs psychiatric help and education, and therapy is need,d
for the whole family.
.
Mr. Jose h Arnold
d
Church o Chr st.
r. rno
e
a
e comm
ee a no
heard from enough disciplines concerned with drug use to develop a
comprehensive idea on a total drug legislation program. The committee should listen to authorities from certain religious elements,
artists, and the intellectual element of society, Mr. Arnold· said.
Each of these groups claim that use of hallucinogenic drugs benefits thei~ group in some way, and these people should be given a
chance to explain their point of view and to prove their claims
about drug use.
From a personal view, Mr. Arnold favored drug legislation
along the lines adopted by the federal government with penalties for
illegal sale, distribution, and manufacture of drugs. He pointed
out that young people should not be made felons because of their
experimenting mind. Mr. Arnold urged the committee not to be pushed
into hasty drug legislation by public pressure since the lives affected most by drug legislation are adolescents.
Dr. Alan Frank Ps chiatrist Stude t Healt Servic s
versity of Colorado.
Dr. Fran spo e tote comm ttee as a
psychiatrist, not as a member of the University staff. The drug
abuse problem was said to be impossible to solve. The use of dangerous drugs is basically a moral issue or conflict between generations. Legislators have to separate moral attitudes from objectivity in reaching a decision on the use of drugs. The older elements
of society generally reject drug abuse, and the younger generation
is more willing to experiment with new ideas. Dr. Frank pointed out
that use of alcohol, tobacco, and coffee were capital crimes in
various parts of the world during the 18th Century. The question

35

W.
W

Ibid., pp. 39 - 41.
Ibid., September 7, 1967, pp. l - 6.
Ibid., June 28 and 29, 1967, pp. 36 - 39.

-24-

to be answered before legislation 1s passed is where do these drugs
fit into society.
Dr. Frank said that while he did not advocate use of dangerous drugs, he was opposed to severe possession penalties. Drug
legislation should be concerned with the sources of dangerous drugs.
The best approach to the LSD problem was through education,
Dr. Frank stated. Explain all aspects of LSD in terms adolescents
can understand; talking in adult terms gives young people the impression that what is said about LSD is adult propaganda. If adolescents are given the proper education, at least they will be able
to make an intelligent decision on whether or not to take LSD when
they are confronted with the situation.
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APPENDIX A
COMPILATION OF FEDERAL LAWS
REGARDING NARCOTICS AND DRUGS

Harrison Narcotic Act. Termed the first effective narcotics
control measure, this law initiated a policy which is still the
basis of present drug control programs. Enacted as a revenue
measure, the Treasury Department is designated as the enforcement
agency.
As a revenue measure, the Harrison Act imposes a tax of one
cent per ounce on narcotic drugs produced or imported in the United
States and sold or removed from consumption or sale. The tax is
imposed upon the following narcotic drugs: opium, isonipecaine,
coca leaves and opiates; compounds, manufactures, salts, derivatives,
or preparations of the foregoing; and substances chemically identical
to the foregoing.
Payment of the tax must be evidenced by stamps affixed to the
package or container. No person may purchase, sell or distribute
narcotic drugs unless he does so from a stamped package. Possession
of narcotics in unstamped containers is "prima facie evidence of a
violation."
The act allows•the Secretary of the Treasury to determine
whether a pharmaceutical preparation containing a narcotic drug
combined with other ingredients should warrant application of the
law. Except for the dispensing of narcotic drugs to a patient by
a practitioner "in the course of his professional practice only"
and the sale, dispensing, or distribution of narcotic drugs by a
dealer to a consumer in pursuance of a practioner's prescription,
sale or transfer of narcotic drugs is unlawful except in pursuance
of a written order or a recipient on an official form supplied by
the Treasury Depar\ment.
Persons in the vocation involving the handling of narcotic
drugs must register annually with the Treasury Department and pay
an occupational tax graduated from one dollar to 24 dollars per
year. They are also required to keep records, make them available
to law officers, and file returns as required by the Secretary of
the Treasury.
Traffic in narcotic drugs without registration is a separate
offense, independent of failure to register. Thus, the transportation of narcotic drugs in interstate commerce by persons not
registered is prohibited except for employees and agents of registrants within the scope of their employment or other authorized
persons within the scope of their employment.
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marihuana, morphine, opium, paraldehyde, ~eyote, or suphonmethaneor chemical derivatives of the foregoing.
2) Prescription is required for the dispensing of a drug
intended for use by man whichi
(a) contains certain narcotic and other substances or substances designated by regulation as "habit forming,"
(b) is not safe except under the supervision
of a licensed practitioner because of its
potentiality for harmful use, or
(c) is limited to use under the professional
supervision of a licensed practitioner under
procedures for the introduction of new drugs
into interstate commerce.
3) No new drugs may be introduced into interstate commerce
unless an application filed with the Secretary of Health, Education
and Welfare is in effect with respect to such drug.
4) Annual registration is required of establishments that
manufacture, c6mpound, or process drugs and that wholesale or
distribute any depressant or stimulant drug. The 1962 Drug Act
established registration requirements. The depressant and stimulant
drug registrations were added by the Drug Abuse Control Amendments
of 1965 which established special federal control~ over depressant,
stimulant, and hallucinogenic drugs.
Section 301 of the Federal Food, Drug and Cosmetic Act, as
amended in 1962 and 1965, enumerates prohibited acts as followsi
(a) Introduction or delivery into interstate commerce of
adulterated or misbranded foods, drugs, devices, or cosmetics.

state.

(b)

Their adulteration or misbranding in interstate commerce.

(c)

Their receipt and delivery in adulterated or misbranded

(d) The introduction or delivery into interstate commerce
of any article in violation of temporary permit controls (~pplicable
to food) or in violation of procedures for the introduction of new
drugs.
(e) Refusal to permit access to records of interstate shipment of food, drugs, devices, or cosmetics or to make records or
reports required under procedures for the introduction of~ "new
drug."
·

.

(f) Refusal to permit entry and inspection of certain
establishments in which foods, drugs, devices, and cosmetics are
manufactured or held.
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(g) Manufacture of adulterated or misbranded foods, drugs,
devices, and cosmetics.
(h) The giving of certain false guarantees regarding good
faith in receiving or delivering such articles.
(i) Certain false use of identification devices required
under law, doing of certain acts which cause a drug to be counterfeit,
or the sale, dispensing, or holding for sale or dispensing of a
counterfeit drug.

(j)

Misuse of trade secret information.

(k) Certain acts resulting in adulteration or misbranding of
foods, drugs, devices, or cosmetics in interstate commerce.
(1) Represeriting or suggesting in labeling or advertising
that approval of a new drug application is in effect or that the drug
complies with new drug introduction procedures.
(m)

Violation of laws governing the coloring of margarin~.

(n) The use in sales promotion of any reference to a report
or analysis furnished under inspection procedures.
(o) In the case of prescription drugs, failure of the manufacturer, packer, or distributor to maintain or transmit to requesting practitioners true and correct copies of all printed matter
required to be included in the drug package.
(p) Failure of drug manufacturers and processors and depressant or stimulant drug wholesalers, jobbers, or distributors
to register with the Secretary of Health, Education, and Welfare.
(q) Relative to stimulant or depressent drugs: manufacturing, processing, or compounding, except by registered drug firms for
legal distribution; distributing such drugs to persons not licensed
or authorized to receive them; possession of stimulant or depressant
drugs except as authorized by law; failure to prepare, obtain, or
keep required records, and to permit inspection and copying of such
records; refusal to premit entry or inspeciion as authorized; filling or refilling prescriptions for these drugs in violation of law.
Imprisonment for not more than one year or a fine of not more
than $1000, or both, is the penalty for violation of any of these
prohibitions. If the violation is committed after a previous conviction has become final, or is made with intent to defraud or mislead, the violator is subject to imprisonment for not more than
three years or a fine of not more than $10,000. or both.
Drug Abuse Control Amendments. In January, 1963, President
Kennedy established a President's Advisory Commission on Narcotic
and Drug Abuse. The Commission made 25 recommendations, the influence of these being seen in the amendments of 1965.
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The Drug Abuse Control Amendments of 1965 impose more
stringent controls on stimulant, depressant, and hallucinogenic
drugs. The new law, which became effective in 1966, begins with a
declaration by Congress that these drugs need not move across state
lines to be subject to its regulations. The law notes that "in
order to make regulation and protection of interstate commerce in
such drugs effective, regulation of intrastate commerce is also
necessary'' because of the difficulties of determining place of
origin and consumption and because relulation of interstate but not
intrastate commerce "would discriminate against and adversely affect
interstate commerce in such drugs."
The amendments add to the body of law a definition of
depressant or stimulant drug asr
(a) one which contains barbituric acid or its salts or a
derivative therefrom which has been designated under federal law
as habit forming;
(b) one which contains amphetamine or its salts or a substance designated as habit forming by the Secretary of Health,
Education, and Welfare because of its stimulant effect on the
central nervous system; and
(c) one containing a substance designated by regulation as
having a "potential for abuse" because of its depressant or stimulant effect on the central nervous system or its hallucinogenic
effect. Narcotic drugs are specifically excluded.
Lysergic acid and lysergic acid amide are drugs covered by
the amendments of 1965, along with mescaline and its salts, peyote,
and psilocybin. The act also prohibits the possession of depressant
or stimulant drugs except by seven classes of persons--who can be
generally described as manufacturing or doing research upon the
drugs.
No prescription for a depressant or stimulant drug may be
filled or refilled more than six months after the date of its
issuance, and no refillable prescription may be refilled more than
five times. However, prescriptions may be renewed, in writing or
orally (if reduced to writing and filed by the pharmicist), by the
prescribing practitioner and then again refilled to the same extent
as an original prescription.
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APPENDIX B
NARCOTIC AND DANGEROUS DRUG LEGISLATION IN OTiiER STATES
I.

State Narcotic Laws

Narcotics
Narcotics are divided into five groups by federal law and
the uniform state narcotic laws: (1) opium and its derivatives -morphine, heroin, etc.; (2) coca leaves and its derivatives (cocaine):
(3) cannabis (marihuana); (4) the meperidine (pethidene) group; and
(5) opiates (substances with an addiction forming or sustaining liability similar to morphine or cocaine).
Even though marihuana and cocaine are defined as narcotics
by law, pharmacologists report that marihuana is a mild hallucinogen
and cocaine is a strong stimulant, and, except by law, neit~er drug
is related in any way to the narcotic family. (For further discussion of characteristics of drugs, see President's Crime Commission
Report, p. 213.)
Uniform Narcotic Drug Laws
The uniform narcotic drug act was first promulgated by the
Commissioners on Uniform State Laws in 1932. Except for California
and Pennsylvania, all states have adopted the Uniform Narcotic Drug
Act. However, both California and Pennsylvania have narcotic drug
laws which are described on pages 8 and 9 of this memorandum.
In general, the important features of the Uniform Narcotic
Drug Law are as follows: (1) licensing of pharmacists selling or
distributing narcotics; (2) licensing of manufactures of narcotics:
(3) records of narcotics dispensed must be kept by physicians,
dentists, veterinarians, pharmacists, manufactures, and anyone else
who can legally dispense narcotic drugs; (4) a listing of narcotic
drugs that are exempt from law; (5) authorized possession of narcotic drugs; and (6) severe penalties for illegal manufacture, sale,
distribution, and possession of narcotic drugs. Marihuana has no
known medical use and possession of this drug is illegal under provisions of the Uniform Narcotic Act. Possession of heroin is also
illegal, and federal law bans importation of heroin.
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States Which Have adopted the Uniform Narcotic Drug Law, and An;t
General Statutory Change The~efrorn
Uniform Narcotic. Drug Act
Table of States Wherein Act Has Be.en Adopted*
State

Year
Enact~

Alabama

1935

Alaska

1943

Arizona

1935

Arkansas

1937

Colorado

1935

Connecticut

1935

General S~atutory N_ote s**
Inserts two sections relating to
notice, hearing and commitment of
drug addicts. Code of Ala., Tit.
22, §§ 249, 250.

Inserts section providing for confinement and treatment in the state
hospital for the insane of persons
convicted under this act. A.R.~;.
§ 36-1022.

Includes a section providin9 for
search and seizure on a sworn complaint or affidavit.
Laws 1955, c. 188, added section providing for regulations for enforcement and for public hearings upon
proposals to promulgate new or amended regulations. C.G.S.A. §§ 19-244
et seq.

Delaware

1935

Inserts sections relating to confinement and treatment of addicts
and manufactur~, possession and sale
of hypodermic needles. 16 Del. C.
§§ 4714, 4716.

Florida

1953

Inserts section providing for examination and treatment of habitual
users of narcotic drugs, which was
amended by L. 1935, c. 17120; L.
1947, c. 23823, § 2; L. 1949, c.
25035, § 11; L. 1951, c. 26484, §
10; L. 1953, c. 28233, § 4, and L.
1955, c. 29615, § 33. F.S.A. §
398.18.
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Year

State
Georgia

Enacted
1935

General Statutory Notes**
Inserts section providing for filing
of an affidavit as to use of narcotic
d:rugs, and investigation and treatment of users of any narcotic drug.
L. 1952, p. 324, § 9, substituted
"Georgia State Board of Pharmacy" for
"State Commissioner of Agriculture"
wherever appearing in the Act. Code
§§ 42-815, 42-818, 42-820.

Hawaii

1931

Adopts Uniform Act, but makes so
many changes that it is not feasible
to set out differences.
Laws 1929, Act 71, § 3, provided for
use of word "podiatrist" wherever
necessary in this Act. R.L.H. 1955
§§ 52-10 to 52-39.

Idaho

1937

Inserts section providing for punishment of violations for which no penalty is specifically provided. I.e.
§ 17-2822.

Illinois

1957

Laws 1957, p. 2569, repealed original
enactment by L: 1935, p. 723, and enacted a new act which is substantially
similar to the Uniform Act, but contains many variations and additional
phraseology which are impractical to
indicate by statutory notes. S.H.A.
ch. 38, §§ 22-1 to 22-49.

Indiana

1935

Iowa

1965

Substitutes "pharmacist" for "apothecary" throughout and inserts section
relating to search warrants.
Laws 1965, c. 195, repealed provisions
of the Uniform Narcotic Act adopted by
L. 1937, c. 114 and reenacted new
provisions substantially similar to
the Uniform Act but which include
numerous changes, additions and
omissions which are impractical to
indicate by statutory note. I.C.A.
§§ 204.1-204.25.
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Year
Enacted

General Statutory Notesff

Kansas

1957

Contains an additional section relating to the adoption of ordinances
by cities to control traffic in narcotic drugs, and substitutes "pharmacist" for "apothecary" throughout
Act. G.S. 1959 Supp. § 65-2501 et seq.

Kentucky

1934

Inserted provisions relating to the
power of the State Board of Health
or the State Dept. of Health to maintain action to restrain or enjoin any
violation of this Act; search and
seizure, and possession, sale or use
of narcotics in penal institutions.
KRS 218.010 et seq.

Louisiana

1934

Inserts section providing for searches
and seizure, affidavits and warrants,
and penalties for making false affidavits. LSA-R.S. 40:972.

Maine

1941

Laws 1965, c. 431, § 16 added provision relating to forfeiture of contraband narcotics and making destruction of substance in premises to be
searched, prima facie evidence that
destroyed substance was unlawfully
possessed narcotics. 22 M.R.S.A.
I 2367.

Maryland

1935

Inserts section regulating possession
of hypodermic syringes and needles,
Code 1957, art. 27, § 297.

Massachusetts

1957

Enacted provisions relating to the
sale, possession and distribution of
narcotic drugs which are patterned
after the Uniform Act provisions, but
because of the many variations therefrom which cannot be set out in statutory notes, reference should be made
to the State code. M.G.L.A. c. 94,
§ 197 et seq.

Michigan

1937·

Minnesf>ta

1937

Mississippi-

1936

Inserts section relating to enforcement of act. M.S.A. § 618.12.
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State
Missouri

Year
Enacted
1937

General Statutory Notes...,
Laws 1953, p. 625, added section
. relating to search warrants, and
seizure of narcotics.
Laws 1957, p. 679, inserted provisions relating to forfeiture of
vehicle or craft transporting narcotic drugs, and regulations by the
director of division of health.
Sections 195.025, 195.135, 195.145,
195.195, RSMo 1959, V.A.M.S.

Montana

1937

Nebraska

1935

Nevada

1937

New Hampshire

1963

New Jersey

1933

New Mexico

1935

Contains numerous additional provisions. 1953 Comp. §§ 54-7-1 to
54-7-49.

New York

1933

Adds sections setting up the bureau
of narcotic control, and relating to
use of opium pipes and to obtaining
drugs from one physician while under
treatment from another. McKinney's
Public Health Law, §§ 3302, 3303,
3304, 3312, 3340, 3343, 3350, 3351.

North Carolina

1935

Inserted provisions relating to the
possession of hypodermic syringes
and needles, growing narcotic plants
by unlicensed persons, seizure and
forfeiture of vehicles, vessels or
aircraft used in transporting narcotics, and reports by physicians.
G.S. §§ 90-108, 90-111.l to 90-111.3.

Inserts five sections relating to
search, seizure and forfeiture of
drugs. R.C.M. 1947, §§ 54-112 to
54-116.

Adopted Uniform Act by L. 1933, c.
51; Comp. Laws§§ 5090 to 5090.25.
This enactment, however, was held
unconstitutional because of defective title, and the Uniform· Act was
again enacted, without reference to
the prior statute, by L. 1937, c.
23. N.R.S. 453.010-453.240.
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Year

State

Enacted

North Dakota

1917

Ohio

1935

General Statutory Notes-IHILaws 1955, p. 178, amended entire act
which contains many variations and
additional phraseology which are impractical to indicate by statutory
notes.
Laws 1959, p. 1044, amended provisions relating to record of drugs,
drug contents, exemptions and penalties, but because of the many
variations from the Uniform Act,
.
reference should be made to the State
Code. R.C. § 3719.01 et seq.

Oklahoma.

1935

Contains additional provisions relating to classification of new prod•
ucts as narcotic drugs and dispensation of narcotics on oral prescription pursuant to the rules and regulations of the Secretary of Treasury
of the United States. 63 Okl. St.
Ann. §§ 401.1• 425.

Oregon

1935

Adds following section: "The Board
of Pharmacy shall make all needed
rules and regulations for carrying
the provisions of this act fnto
effect."
Laws 1961, c. 572, added provisions
relating to exempt status of narcotics.
ORS 474.010-474.990.

Rhode Island

1934

South Carolina

1934

South Dakota

1935

Tennessee

1937

Contains several additional sections. Gen. Laws 1956, §§ 21-28-1
to 21-28-67.

Act contains an additional provision relating to proceedings
before licensing boards. T.C.A.
§ 52-1317.
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State

Year
Enacted

General Statutory Notes**

Texas

1937

Laws 1953, c. 328, p. 812, § -5,
added a section requiring fingerprinting and photographing of persons arrested and persons convicted,
and requiring the courts to notify
the Department of Public Safety of
the disposition of any case.
Vernon's Ann. P.C. art. 725b, § 18a.

Utah

1953

Repealed original enactment by L.
1935, c. 80, and enacted a new act
which is substantially similar to
the Uniform Act as amended in 1952;
includes a section providing for
seizure and disposition of narcotics
and dope pipes or apparatus. U.C.A.
1953, 58-13a-1 et seq.

Vermont

1951

Laws 1951, No. 170, §§ 135-158, repealed original enactment by·L. 1945,
No. 113 and reenacted substantially
similar provisions. 18 V.S.A. §§
4141-4163.

Virginia

1934

Washington

1959

Inserts section relating to search
and seizure.
Laws 1959, c. 27 repealed the former
adoption by L. 1951, c. 22 and reenacted substantially similar provisions. RCW 69.33.220-69.33.970.

West Virginia

1935

Inserts three sections relating to
search warrants, chloral hydrate and
malonylurea. Code, §§ 16-8A-19 to
16-8A-21.

Wisconsin

1935

Adds sections relating to advertising narcotics, possession of
opium pipes, possession and use of
marijuana and drug addicts. W.S.A.
161.26 to 161.30.
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State
Wyoming

Year

Enacted

General Statutory Notes**

1937

Inserts section relating to issuance of warrant. W.S. 1957, § 35362.

* Quoted from Uniform Laws Annotated, Volume 98, 1966, pp. 409-410,
412-414.
** Because of the numerous amendments to the various state enactments of the Uniform Narcotic Drug Act, it is not feasible to
attempt to show all of the resulting variations by statutory
notes, and it is suggested that reference be made to the particular
state code for the text of the corresponding provisions.
States Which Have Not Adopted the Uniform Narcotic Drug Law
California has a comprehensive narcotic law which is found in
West's Anno. California Codes -- Health and Safety, Section ·11000 et
seq.
All drugs found in the uniform narcotic drug law are listed
under California's narcotic drug law, although California lists each
drug separately (Sec. 11001). California also has provisions for
an exempt list (Sec. 11200) and provisions for keeping records (Ch.
3, Arts. 3-6) which are also similar to the uniform law. Unlike
the uniform law, California has made provisions for a Division of
Narcotic Enforcement found in the State Department of Justice (Sec.
11100). The chief and all inspectors of the division have all of
the powers and duties of police officers of the state (Sec. 11105).
Physicians dispensing narcotic drugs are licensed by the
state and, upon the request of the physician or upon request of
the state, a physician can have his narcotic license revoked (Sec.
11163). Narcotic addi-cts cannot receive narcotics from a physician
unless the addict has received permission from the division (Sec.
11164). California's narcotic law provides for treatment of narcotic addicts (Ch. 4, Arts. land 2).
The penalties for illegal manufacture, sale, distribution,
transportation, and possession of narcotic drugs, including marihuana
and cocaine, are generally more severe than the uniform narcotic drug
law (Ch. 5). For example, illegal transportation and illegal sale or
distribution carries a felonr penalty of from five years to life for
the first offense (Section 1 531).
The final chapter of the California narcotic law, Chapter 7, provides for enforcement of the law.
The Pennsylvania drug law includes the same features as
contained in the uniform narcotic drug law. (Purdon's.Penna.
stat. Anno., Vol. 35, Health and Safety -- Ch. 6, Section ?80 et
seq.) However, the Pennsylvania act is unique because it includes
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provisions for both narcotics and dangerous drugs which other states
usually provide in separate statutes.
II.

Current State Laws Controlling Dangerous Drugs

Dangerous Drugs
The dangerous drug classification, as described by the
federal food and drug administration, contains four large categories of non-narcotic drugs for control purposes. (Under federal
law both marihuana and cocaine are narcotics.) The four groupings
are: (1) depressants; (2) stimulants; (3) hallucinogens; and (4)
combinations drugs -- stimulants and depressants combined.
The depressants are probably the most dangerous of this
group because tolerance develops -- larger quantities of the drug
are required to receive the same effects -- and both physical and
psychological dependence develops. During withdrawal, the abstinence syndrome is present and, unless proper medical care is given
to the addict, he may die during withdrawal. Medical author'ities
believe that addiction to depressants presents a greater danger
than addiction to narcotics. Under current federal law, the depressants which are controlled (by generic classification and not
by trade names) include: (1) Chloral hydrate (chloral); (2)
ethchlorvynol (placidyl); (3) ethinamate (valmid); (4) glutethimide
(doriden); (5) methyprylon (noludar); (6) paraldehyde; l7) lysergic
acid; (8) lysergic acid amide; (9) chloral betaine (beta-chlor);
(10) chlorhexadol (lora); (11) petrichloral (periclor); (12)
sulfondiethylmethane (tetronal); (13) sulfonethylmethane (trional);
(14) sulfonmethane (sulfonal).
Stimulants are drugs which stimulate the central nervous
system. Like depressants, tolerance can develop for stimulants.
However, physicians agree that physical dependence does not develop
so there are no withdrawal symptoms from stimulants. Stimulants do
create a psychological dependence. Stimulants controlled by federal
law (by generic classification) include: (1) d-f dl-methamphetamine
(d-, dl-desoxyephedrine) and their salts, and (2J phenmetrazine
(preludin) and its salts.
Probably the greatest controversy in recent years has been
over the use of hallucinogens. There is, at present, no known
medical use for these drugs, and they are legally available only to
qualified clinical investigators. Experimentation with hallucinogens
has brought many controversies into the foreground. As was discussed
in committee hearings, some researchers claim that LSD can cause
damage to the chromosomes. Other investigators believe that prolonged use will cause permanent damage to the normal brain patterns.
What is known about these drugs are: (1) tolerance does not
develop; (2) there is no physical dependence, which means there
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are no wi thclrawal syrnpt-ern's; · ( 3) 'f>'sychological dependence probably
can develop,_ stic-h as irn 'U'se of alcohol and tobacco; and (4) peo- ·
ple who use hallucinogens. continu'ously probably have some inner
problems whlch are removed when t 11¥e hallucinogenic drug is
administered.
Curre-nt f-ederal l~w 'cOnt~ts the following hallucinogerlic
drugs (by 9enericcla~sifieati~n): (1) DMT ~dimethyl-tryptami'ne,);
(2) LSD; LSD-25 {d-lysergi,c acid diethylamide); (3) mescaline and
its salts; (·4) peyOt'e (~visio'n_s <>f the federal law do 11ot _apply
to ncrh-drug us-e in bona fhi-e religi-ous ceremonies of t-pe N·ative
American Church.); (5) .Y,silocybin~ psilocibi,n; (6) psil6cyn,
psilocin.
Model_ State JJrug Abu.se. Co.ntr.o:l. Ac..t
The model state drug abuse act was promulgated by the U.S.
Department of Heal th, Educati'on, and. Welfare. This act has the
endorsement of the pharmaceutical m·a"t,uf actures because a unif·orm
act will make 1 t easier to ·tneiet state r·egµlations. The Federal
Bureau of Drug Abuse Gonttol elso w~uld like to have the act'
passed because it is very similar b:, federal law. A drug abuse
act would also aid the bureau bee-ause the bureau could then work
with local police agenties.
Important features of the a:Ct include: ( 1) requires a
system of record keeping for al~ ~~~ple dealing with dangetous
drugs; { 2) pt-ov!des for inspectliefts of records; ( 3) gives in·spector
all powers and duties of other le\19 enforcem~nt agencies; {4} gives
the inspector powers of seateh end s1!lzure: (5) provides penalties
for illegal ~anufattu~e, sal~ or dtst~ibution, and possession
(penalties are left to tht_di~tt~tlon of the state); and(~)
seizure of illegal drugs ~ithout, a search warrant and possible
confiscation of vehicles lnvolve'cf in transportation of illegal
dangerous drugs.
Dangerous .D;cugs. Con.trolled. Bi States
State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia

0 .epr.e s.s a..o.'t•·*
s Hallu,cimigens*

Stimulants*

M
X
X
)t
X

Possibly**
X
,t

X
X
X

Peyote only
X

X

X

X

X

X

X

X

X
X
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~

State
Hawaii
Idaho
Illinois
Indiana
Iowa

Depressants* Hallucinogens*

Stimulants*

X
X

X
X

X
X

X

X

X

X

X

Kansas
Kentucky
Louisiana
Maine
Maryland

X
X
X
X

Massachusetts
Michigan
Minnesota
Mississippi
Missouri

X
X
X
X
X

X
X
X

X
X
X
X

X

X

Montana
Nebraska
Nevada
New Hamp·hire
New Jersey

X
X
X

X
X
X

X
X
X

X

X

X

New Mexico
New York
North Carolina
North Dakota
Ohio

X
X
X
X
X

X
X
X

X
X
X

Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina

None

X

X
X

Possibly**

X
X
X
X

X

X

X

Possibly**
X

Possibly**
Possibly**

X
X

X

South Dakota
Tennessee
Texas
Utah
Vermont

X
X
X
X

X
X
X

Virginia
Washington
West Virginia
Wisconsin
Wyoming

X
X

Possibly**
X
X
X
X
X

X
X

X

X

X
X
X

X

X

X

*

X
X
X
X
X

These classifications are broad, and some states do not control
all drugs under the general classification.
,** Any state which has given the authority to an agency to name
dangerous drugs could have already included these drugs under
rules and regulations which would not be found in the statutes.
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States Which J:lave Adpp.t~d th, Mgc;l~l Drug .Ab,u,sg Cp.n.trol Act
Chapter

Arkansas -- Arkansas Statutes Anno •• Vol 7A, Title 82

1.

Arkansas recently passed the model drug abuse control act,
However, the law library does not have Arkansas' 1967 Session Laws
at this time, and the staff is unable to provide the ~xact citation.
From information received from the Federal Bureau of Drug Abuse
Control, Arkansas has provisions for 9trong possession penalties,
seizure of controlled dangerous drugs without a s@l~ch wattant, and
state inspectors have all police powe~s.
Georgia -- Code of Georgia Anno., Book 14A, Title 42
Georgia Laws of 1966, Vol. 1, Chapte~ 501

42-7 and 42-99.
p. 371.

Chapte~
ts.a.
80)

With the 1966 am~ndm~nt to Georgia's Dangerous Drug Act (Ch.
42-7), Georgia has all of the provisions found in the modfl drug

abuse control act-· Chapter l; Section l; Ga. L. 1966, page 372.
The penalty for violation of the dangerous drug law ig a misdemean~r.
Hawaii•- Hawaii adopted the model drug_abuse control act in
1967. Hawaii's 1967 Session Lawe are not available, and a citation
cannot be given. Acco~ding to information ~eceivtd from the Federal
Bureau of Drug Abuse Control, Hawaii's law includes: (1) possession
penalties; (2) seizure of illegal dangerous drugs without a search
warrant; and (3) seizure of vehicles used in transporting illegal
dangerous drugs. All other f~atu~es of th~ model act are the s•me,

Idaho -- Idaho Code, Vol, 7, Health and Safety, Title j7,
Chapter 3~.
Idaho has adopt~d the mod~l drug abuse control act~ The
agency administering the law is the Idaho Stata Bc,ard of Pharmacr
(Sec. 37-3320). The penalty for illegal manufacture, i11egal 9a e
or distribution, illegal possession, and selling counterfeit drugs
is a felony. Violations of other prohibited acts is a misdemeanor
(Sec. 37-3304).
Minnesota -- Minnesota had laws regulating depressQnt drugs
and peyote. but in the 1967 legislative session, Minnesota passed
the model drug abuse control act, This information was re~eived
from the Federal Bureau of Drug Abuse C~ntrol, and since Minn~sota
has not sent their 1967 Session Laws to the law library, the staff
is unable to provide a statute citation.
Nebraska -- According to the Federal Bureau of Drug Abuse
Control, Nebraska adopted the model drug abuse control act, Unlawful possession of dangerous drugs is subject to seizure without
a search warrant, and vehicles used in t~ansportation of illicit
dangerous drugs are subject to confiscation.
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New Jersey -- New Jersey Session Law Service, 1967, No. 1,
Chapter 314, p. 25 et seq.
New Jersey has adopted the model drug abuse control act.
There are no special provisions for confiscation of illicit dangerous drugs or vehicles used in transportation of illegal dangerous
drugs. Penalty for violating the act is a misdemeanor, punishable
by fine only (Sec. 9, p. 31).
New Mexico -- New Mexico Statutes 1953, Vol. 8, Part 2,
Sections 54-6-25 to 54-6-51.
Controlled drugs are stimulants, depressants, and hallucinogens (Sec. 54-6-27F). Illicit dangerous drugs are subject to
seizure without a search warrant. Vehicles transporting these
drugs are also subject to confiscation (Sec. 54-6-31). Penalties
for violation of the New Mexico Drugs and Cosmetics Law are: (1)
violation of Sec. 54-6-28A, B, C, and G is a misdemeanor on first
offense and a felony on the second and subsequent offenses (illegal
manufacture, illegal sale or distribution, and illegal possession
of dangerous drugs) -- Sec. 54-6-51A.
New York -- New York has passed the model drug abuse act
controlli .. g dangerous drugs, but no further information is available.
South Carolina -- Code of Laws of South Carolina, Vol. 7,
Title 32, Section 32-1505 et seq.
During the 1966 legislative session South Carolina passed
the model drug abuse control act, controlling stimulants, depressants, and hallucinogens (Sec. 32-1505). Seizure of illegal
dangerous drugs may be made only if a search warrant has been
properly executed lSec. 32-1510.2). No provisions are made for
confiscating vehicles used in transportation of illegal dangerous
drugs. Penalties for violation of the law include: (1) first
offense a misdemeanor -- maximum $2,000 fine or two years imprisonment or both; (2) second offense -- fine of not less than $2,000
nor more than $5,000 or imprisonment of not less than two nor more
than 5 years -- discretion of the court; and (3) third and subsequent offenses -- imprisonment of not less than five nor more than
ten years with no probation or suspension. Sec. 32-1510.3.
Tennessee -- From information received from the Federal
Bureau of Drug Abuse Control, Tennessee passed the model drug abuse
control act during the 1967 legislative session, but no further
information is available.
Utah
to 58-33-8.

Utah Code Anno., Vol. 6, Title 53, Sections 58-33-1

During the 1967 legislative session, Utah passed the model
drug abuse control act, which controls stimulants, depressants, and
hallucinogens (Sec. 58-33-1). Utah law gives authority to the
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department of business regulation to seize illegal dangerous drugs
and vehicles used in transportation of illegal dangerous drugs
without a search warrant (Sec. 58-33-5). Penalties include: (1)
sale to a minor -- felony; and (2) any other violation is a misdemeanor (Sec. 58-33-4).
Virginia -- Code of Virginia, Vol, 1. Title 54, Sections
54-446.3 to 54-446.13.
Virginia has adopted the model drug abuse control act.
Controlled drugs are stimulants, depressants, and hallucinogens
(Sec. 54-446.3}. It is unlawful to illegally possess, sell or
distribute, or manufacture these dangerous drugs (Sec. 54-446.4).
Records are to be kept for three years (Sec. 54-446.5). The law
makes no mention of seizure of dangerous drugs or seizure of
vehicles transporting illegal dangerous drugs. Penalties for
violation of the act include a misdemeanor for the first offense
and a felony for any subsequent offense (Sec. 54-446.11).
Wyoming -- Session Laws of Wyo~ing, 1967, Chapter 158,
pp. 462-471.
Wyoming has enacted the model drug abuse control act which
controls stimulants, depressants, and hallucinogens (Sec. 1, p.
463). Illegal dangerous drugs can be seized with a search warrant
and vehicles used in transporting-illegal dangerous drugs can be
confiscated (Sec. 5, p. 465). Penalty for violation of the law is
a misdemeanor (Sec. 4, p. 465).
. ·
States Controlling Stimulants, Depressants. and Hallucinogens or
Have Given an Agency Authority to Add Dangerous Drugs to a Dangerous
Drug List, but Have Not Adopted the Model Drug Abuse Control Act
Arizona -- Arizona Revised St~tutes Anno., Vol. 10, Section
32-1964 to 32-1975.
·
Ariz~na cbntrols stimulants an~ depressants~ and iri addition
the state board of pharmacy has the authority to add dangerous drugs
to the list (Sec. 32-1964). Records of sale of dangerous drugs
shall be kept for five years (Sec. 32-1965). Arizona law makes it
unlawful to illegally sell or possess-dangerous drugs (Sec. 32-1968).
The penalty provided by the law is a m~sde~eanor (Sec. 32-1975).
California -- West's Anno. California·codes; Business and
Professions Section 4210 et seq. and Health and Safety Section
11901 et seq.
Stimulants and depressants are controlled drugs in California
Business and Professions Code Section 4211. Everyone dealing with
· stimulant.and depressant drugs are required to obtain a license from
the state (Sec. 4222). Whenever stimulant or depres~ant drugs are
administered or dispensed records of the sale have to be kept (Sec.
4227 and Sec. 4232). Possession of stimulant or depressant drugs
without a prescription is illegal (Sec. 4230). Any violations of
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the dangerous drug law will carry the penalty of a misdemeanor
(Sec. 4233), and in tp~ case of a doctor or pharmacist, conviction
may result in suspeniJ6n or revocation of any license issued under
the provision of the .Business and Professions Code (Sec. 4238). The
state board of pharmacy $hall have inspectors with powers and duties
of legally empowered: p,e,ace officers (Sec. 4221) • Inspectors shall
have the power to inspect inventory stocks of dangerous drugs and
records pertaining to sale of dangerous drugs (Sections 4231 and
4232).
.
·
In 1966, California passed a new law restricting dangerous
drugs. This law included stimulants, depressants, and hallucinogenic drugs (LSD and DMT) -- Health and Safety Code, Section 11901.
Unlawful possession of restricted drugs shall on the first offense
be a misdemeanor and ,u~Qn each offense thereafter a felony (Sec.
11910). Unlawful sale o,.r <::listribution, manufacture, transportation, etc., shall be a felony (Sec. 11912). Anyone attempting to
involve a minor in restricted dangerous drugs shall be, upon conviction, sentenced tb the ~tate penitentiary (Sec. 11913). The
provisions of the law d9 not apply to legal clinical investigators
of LSD and DMT (Sec. 11916).
Connecticut .. -·The 1967 session of the Connecticut Legislature passed a dangerqU$ drug abuse law; however, the 1967 Connecticut
Session Laws have not been received by the law library and the staff
will not be able to give the citation of the law. According to information received from the Federal Bureau of Drug Abuse Control,
Connecticut's drug a,i;>use law was patterned after the model drug
abuse control act, but the Connecticut law is more comprehensive.
Florida~- Florida Statutes Anno., Title 27, Sections 404.0l
to 404.15.
Controlled drtlgs in Florida are stimulants and depressants
(Sec. 404.01). Prohibited acts include: unlawful possession and
failure to keep records {Sec. 404.02). Anyone dealing with stimulants or depressants' is required to keep records for a period of
two years (Sec. 404.05). Records shall be open to inspectors from
the Florida State Bo~rd of Health (Sec. 404.06). Any stimulants or
depressants not meeting the requirements of the chapter shall be
labeled contraband and shall be subject to seizure and confiscation
by any law enforcem&nt officer (Sec. 404.07). Any vehicle, vessel,
or aircraft carrying lontraband shall also be subject to seizure
and forfeiture (Sec, 404.08). The Florida Board of Health has the
authority to make rules and regulations deemed necessary to implement the law (Sec. 404.12). Penalty for violation of the law is
a felony (Sec. 404.15), Anyone licensed to administer drugs may
have his license revoked upon conviction of any violation of the
law (Sec. 404.14). The Florida Legislature amended Chapter 404 by
adding a new section, Section 404.001. The name of the law was
changed to the Florid~ Drug Abuse Law (Chapter 67-136, 1967 Regular
Session). The only impQrtant change in the law was the addition of
hallucinogenic drtigs to"th~ list of controlled drugs (Sec. 404.01(3)).
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Indiana -- Burns Indiana Statutes Anno., Vol. 7, Part 1,
Health ~ode, Title 35, Sections 35-3331 to 35-3339.
The Indiana Dangerous Drug Act controls stimulants, depres•
sants, and hallucinogenic drugs (Sec. 35-3332J). Unlawful acts
include: (1) illegal sale; (2) illegal possession; (3) failure to
keep records of sales; (4) refusal to permit inspection of records;
and (5) attempting to obtain drugs by fraud (Sec. 35-3333). Upon
conviction of these unlawful acts the penalty is a felony (Sec. 35•
3338).
Louisiana -- Louisiana Revised Statutes 1950, Title 40, Public
Health and Safety, Part X, Narcotics Sub•Part D, Sections 1031 to 1046.
Louisiana law controls stimulants, depressants, and hallucino~
genie drugs (Sec. 1032). Unlawful acts include: (1) illegal sale;
{2) illegal possession; (3) failure to keep records; (4) refusal to
open records to inspectors; and (5) attempting to obtain dangerous
drugs by fraud (Sec. 1033). Louisiana law has provisions for clinical researching of dangerous drugs (Sec. 1035). Records are to be
kept as mar be reasonably required by the state board of pharmacy
(Sec. 1036. The state board of pharmacy shall have the authority
to inspect records (Sec. 1037). All illegallr possessed dangerous
drugs are considered contraband subject to se zure and confiscation
by any law enforcement officer (Sec. 1038). Penalty for violation
of the Louisiana dangerous drug law is a fine of not more than $1,000
or imprisonment in the parish jail for two years or both. For each
subsequent offense punishment shall be not more than a $5,000 fine or
confinement in the state penitentiary for a period of not more than
five years, or both imprisonment and fine (Sec. 1046).
·
Maine•- Maine Revised Statutes Anno., Vol 12, Title 22,
Health and Welfare, Section 2201 et seq., as amended by the Maine
Session Laws 1967.
The board of commissioners of the profession of pharmacy
shall regulate all stimulants and depressants (Sec. 2201). It is
urilawful to possess or sell depressant drugs unless a pre~cription_
fQr the drugs has been obtained from a doctor (Sec. 2210). In the
amended law a new section (2212B) makes it a felony to possess
hallucinogenic drugs. Anyone found with illegal possession of
drugs enumerated in Sections 2201 to 2210 {Narcotic drugs mentioned
in these sections are not discussed) shall be guilty of a felony.
If a person is found under the influence of these enumerated drugs,
the individual is guilty of a felony. Inspectors shall have the
right to inspect all records (Sec. 2215).
Section 2368 {a section in Maine's narcotic law) concerning
licensing of manufacturers and wholesalers was amended in 1967 to
prohibit any manufacturing of hallucinogenic drugs. Clinical researchers shall be licensed and controlled by the bureau of health.
Penalty for illegally manufacturing hallucinogenic drugs is administered under the narcotics penalties.
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Maryland -- Anno. Code of Maryland, Art. 27, Sec. 307 et
seq. and Art. 43, Sections 285 and 289 as amended in 1966.
Maryland defines dangerous drugs as any drug intended for
man which may have potentially harmful effects unless administered
under the supervision of a physician (Sec. 307). The state department of public hP-alth is authorized to promulgate the necessary
rules and regulations for the administration of the act (Sec. 312).
Violation of the act is a felony (Sec. 313). Unlawful acts are:
(1) illegal possession of stimulants and depressants; (2) failure
to keep records; and (3) illegal manufacture of a stimulant drug
Laws of Maryland 1966, Chapter 377, pp. 666-669.
Massachusetts -- Massachusetts General Laws Anno., Ch. 94,
Art. 187A et seq. as amended in 1967.
Under Massachusetts law harmful (dangerous) drugs include
stimulants, depressants, and hallucinogens {Sec. 187A and 1967
Regular Session Ch. 49). Illegal sale is a misdemeanor (Sec. 94187A). Illegal possession of dangerous drugs is a misdemeanor
(Sec. 94-187B).
_Michigan -- Michigan Statutes Anno., Vol. 13, Regulations
Under Police Powers, Title 18, Sections 18.1101 to 18.1108 as
amended.
Michigan law controls the sale and possession of stimulants
and depressants. Records of sale must be kept by all licensed
dispensers of these drugs (Sec. 18.1101). All records must be kept
for a period of two years (Sec. 18.1104). Anyone guilty of, any
violation of Section 18.1101 to 18.1105 is guilty of a misdemeanor.
Anyone distributing, selling, or in possession of any hallucinogenic drugs except exemption provided for by the Federal Food Drug
and Cosmetics Act is guilty of a felony (Sec. 18.1106 -- amended
during the 1966 legislative session, Mich. Stat. Anno., Statute
Release No. 7, p. 305). Administration of the act is carried out
by the state board of pharmacy (Sec. 18.1108).
Missouri -- Missouri Revised Statutes, Cumulative Supplement
1965, Chapter 195.240 et seq.
Illegal possession, illegal sale or distribution, and illegal
manufacturing of stimulant and depressant drugs is a felony in
Missouri (Sec. 195.240 and 195.270). From information received
from the Federal Bureau of Drug Abuse Control, Missouri has included
hallucinogenic drugs under this statute, but the 1967 Missouri
Session Laws are not available and the staff cannot give a citation.
Montana -- Revised Codes of Montana 1947, Replacement 2,
Part 2, Title 27, Section 27-701 et seq.
Stimulant and depressant drugs are controlled in Montana
(Sec. 27-716). Any violation of Section 27-716 shall be deemed a
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misbranding of a drug or device, The penalty for misbranded drugs
or devices is a misdemeanor (Sec. 27-705). It is unlawful to manufacture, sell or distribute, and possess any hallucinogenic drugs
as defined by federal law unless authorized by the Montana Department of Public Health or under provisions of the federal act (Sec.
27-724). Penalty for violation of Section 27-724 is a misdemeanor
on first offense and a felony on the second or subsequent offenses
(Sec. 27-725).
Nevada -- Statutes of Nevada, 1965 Special Session, 1966
Special Session, and 1967 Regular Session, Vol. 2, pp. 1629 et seq.
Nevada controls stimulants and depressants (Sec. 13, p. 1631).
Records of dangerous drugs are to be kept and open to inspection by
authorized inspectors (Sec. 18, p. 1633). Unlawful sale of dangerous drugs to a minor is a felony (Sec. 20, p. 1633). Unlawful possession of dangerous drugs is a misdemeanor (Sec. 21, pp. 1633 and
1634}. Hallucinogenic drugs are controlled by Sec. 48, p. 1636 of
the law. It is a misdemeanor to illegally possess, sell or distribute and manufacture any drug which may not be lawfully introduced into interstate commerce under the Federal Food, Drug, and
Cosmetic Act (Sec. 62, p. 1639).
Nrrth Carolina -- General Statutes of North Carolina, Vol.
2C, Section 90-lll.3 et seq. as amended in 1967.
Stimulants and depressants are controlled drugs in North
Carolina (Sec. 90-113.1). Prohibited acts under the law include:
(1) illegal sale or distribution; and (2) illegal possession of
stimulants and depressants (Sec. 90-113.2). The board of pharmacy
is the controlling agency (Sec. 90-113.6). Records are to be kept
for a period of two years (Sec. 90-113.5). Penalty for violation of
the law is first offense a misdemeanor and each offense thereafter
a felony (Sec. 90-113.7). In 1967 a new subsection (b) was added
to Sec. 90-113.7 which gave the state authority to seize and dispose
of any vehicle, vessel, or aircraft under 7,000 pounds which is
used for transportation of stimulants or depressants.
The North Carolina narcotic drug act was also amended in
1967. Added to the narcotics definition were all hallucinogenic
drugs (Sec. 90-87). The hallucinogens are now subject to all provisions of the uniform narcotic drug law.
Oregon -- Oregon Revised Statutes, Vol. 3, Title 37, Chapter
475.010 et seq.
The drug advisory council has the authority to designate
dangerous drugs (Sec. 475.010). The staff was not able to determine which drugs are controlled in Oregon. Sale or possession of
dangerous drugs without a prescription is illegal (Sec. 475.100).
Violation of Section 475.100 is a misdemeanor (Sec. 475.990 (2)).
Pennsylvania -- Purdon's Penna. Statutes Anno., Title 35,
Section 35-780-1 et seq.
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Dangerous drugs which are controlled are : ,(1) stimulants;
(2) depressants; and (3) any other drug, because of its toxicity
or potentiality for harmful effect is considered unsafe for use
except under a physician administration (Sec. 780-2 (h)). The
secretary of health after consultation with the Pennsylvania Drug,
Device, and Cosmetic Board has the authority to add drugs to the
dangerous drug list (Sec. 780-2 {h)). All possession of dangerous
drugs, except as provided by law, is contraband (Sec. 780-2 lv)).
Records of dangerous drug sales and purchases are to be kept for
two years, and the records are open to inspection by authorized
persons (Sec. 780-9). Any persons dealing in dangerous drugs must
- register with the secretary of health (Sec. 780-11). All contraband drugs are subject to seizure (Sec. 780-12). Unlawful acts
include: (1) illegal manufacturej (2) illegal sale or distribution; and (3) illegal possession \Sec. 780-4 (a)). Penalties for
violation of the dangerous drug portion of the law is a misdemeanor
for the first offense and a felony for each subsequent offense
(Sec. 780-20 {a)).
Texas -- Vernon's Penal Code of the State of Texas, Vol. 2,
Article 726d et seq. as amended.
Dangerous drugs which are controlled in Texas include stimulants, depressants and hallucinogens (Art. 726d, Sec. 1~ as amended
in 1966 and 1967). Prohibited acts include illegal manufacture,
illegal sale or distribution, and illegal possession (Art. 726d,
Sec. 3). Records are to be kept and open to inspection (Art. 726d,
Sec. 6). Dangerous drugs unlawfully possessed are subject to
seizure (Art. 726d, Sec. 8). Penalties include: (1) first offense
a maximum fine of $3,000 or imprisonment for not less than-30 days
nor more than two years or both; and (2) second or subsequent offense
a felony.
Washington -- Revised Code of Washington, Vol. 9, Title 69,
Chapter 69.40 et seq as amended in 1965).
Dangerous drugs are any drugs which require a prescription
(Sec. 69.40.063). Upon receiving a search warrant dangerous drugs
can be seized (Sec. 69.40.100). Any place distributing dangerous
drugs illegally shall be deemed a public nuisance (Sec. 69.40.080).
Unlawful acts include: (1) illegal sale or distribution; (2)
illegal possession; and (3) illegal manufacture of dangerous drugs
(Sec. 69.40.061, 69.40.063, 69.40.080, 69.40.090, and 69.40.100).
Stimulants and depressants are specifically named as dangerous
(Sec. 69.40.060). Penalties for violation of this law include:
(1) first offense -- a misdemeanor; (2) second offense -- gross
misdemeanor -- Maximum of $1,000 fine or one year imprisonment or
both; (3) third or subsequent offense -- a felony; and {4) sale or
distribution to a minor -- a felony (Sec. 69.40.070). According to
information received from the Federal Bureau of Drug Abuse Control,
hallucinogenic drugs were added as controlled drugs during the 1967
regular session. No information is available from the law library
and an exact citation is not possible.
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West Virginia -- Acts of the Legislature of West Virginia
1965, Chapter 133, pp. 503-508.
West Virginia controls stimulants and depressants specifically
and hallucinogens by reference to the federal law and any amendments
to the federal law (Sec. 1(1), p. 504). Prohibited acts include:
(1) unlawful sale or distribution; and (2) illegal possession of
dangerous drugs (Sec. 2, pp. 506 and 507). Regulations to implement this law are made by the state board of pharmacy (Sec. 4, p.
508). Illegal dangerous drugs can be seized with a search warrant
(Sec. 5, p. 508). Penalty for violation of the act is: (1) first
offense -- fine not to exceed $1,000 or imprisonment for not more
than five yearsi and (2) second or subsequent offense -- a felony
(Sec. 6, p. 5081.
States Controlling Some Dangerous Drugs
Alabama -- Act No. 430, Acts of Alabama, Special Session
1966, p. 575.
Alabama law makes it unlawful to possess, transport, deliver,
sell, offer for sale, bater, or give away in any form LSD, psilocybin,
or any other drug or compound known as psycotomimetics (hallucinogens) (Sec. 1). Section 4 of the act provides for a felony penalty
for illegal possession, transportation, and sale or distribution.
Alaska -- Alaska Statutes, Title 17, Chapter 15.
Section 17.15.010 states that it shall be unlawful t~ sell,
barter, distribute, or give away depressant drugs. The penalty for
illegal sale is a misdemeanor (Sec. 17.15.040).
Colorado -- Sections 48-4-1 to 48-4-4, C.R.S. 1963.
Colorado controls sale or distribution of anhalonium and
peyote (Sec. 48-4-2). The penalty for illegal sale is a misdemeanor (Sec. 48-4-3).
Delaware -- Delaware Code Anno., Title 16, Sections 4901 to
4905.

Delaware controls depressant drugs (Sec. 4901). The law requires the keeping of records, and the proper labeling of containers
(Secs. 4903 and 4904). There are no provisions for penalties.
Health.

Kentucky

Kentucky Revised Statutes, Title 18, Public

Depressant drugs are controlled by Kentucky law (Sec. 217.461).
Unlawful acts include: ( 1) ille·gal sale; ( 2) illegal manufacture;
and (3) illegal possession (Sec. 217~462 (1)). Records of sale must
be maintained for at least two years and the records shall be open
to inspection to authorized representat~ves of the state board of

-52-

health and the state board of pharmacy (Sec. 217.511). Kentucky
law controls stimulants under section 217.720. It is unlawful to
illegally possess, sell, and manufacture stimulants (Sec. 217.730).
The state board of health and the state board of pharmacy shall
regulate this law. Inspectors shall have all police powers (Sec.
217.790). There is no specific regulation requiring keeping of
records for stimulant drugs. Penalty for violation of the depressant law is a misdemeanor (Sec. 217.992). Penalty for violation
of the stimulant law is a misdemeanor.
Mississippi -- Mississippi Code 1942, Anno., Vol. 5A, Public
Welfare, Sections 6831-01 to 6831-12.
Controlled drugs in Mississippi are stimulants and depresants (Sec. 6831-01). Prohibited acts include: (1) illegal distribution or sale; (2) illegal possession; and (3) failure to keep records or refusal to allow inspectors to inspect records (Sec. 683102). Manufacturers and pharmacists are required to keep records of
stimulants and depressants for two years (Sec. 6831-05). Records
shall be open to inspectors from the state board of pharmacy upon
written request (Sec. 6831-05). The state board of pharmacy is
authorized to promulgate the necessary rules and regulations for the
administration of the acts (Sec. 6831-07). Violation of this law is
a felony (Sec. 6831-08).
North Da~ota -- North Dakota Century Code Anno., Vol. 3,
Chapter 19, Article 19 et seq.
North Dakota controls depressant drugs (Sec. 19-19-02)
Anyone dispensing depressants must keep records of their depr;ssant drug inventory and records of sale (Sec. 19-19-06). These
records are open to inspection for inspectors from the board of
pharmacy (Sec. 19-19-07}.
It is unlawful to illegally sell or distribute depressants
or illegally possess barbiturates (Sec. 19-19-03). Penalty for
violating the law is a misdemeanor.
Ohio -- Page's Ohio Revised Code, Title 37, Sections 3719.23
et seq.asamended.
Depressants are controlled drugs in Ohio (Sec. 3719.23).
Unlawful acts include: (1) illegal sale or distribution; and (2)
illegal possession (Sec. 3719.24). Inventory and sale records
must be kept for two years (Sec. 3719.26). These records can be
inspected by authorized agents of the board of pharmacy (Sec.
3719.27). Penalty for any violation of the provisions of this
law is a misdemeanor (Sec. 3719.99 (I) (1967)).
Oklahoma -- Oklahoma Statutes Anno., Title 63, Sections
465.11 to 465.19 as amended.
Oklahoma controls stimulant and depressant drugs (Sec. 63465.11). Unlawful acts include: (1) illegal possession; and (2)
illegal sale or distribution (Sec. 63-465.12). Records are to be
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kept for two years, and these records are open to inspection by
agents of the board of pharmacy (Secs. 63-465.13 and 465.17).
Violation of the act is a misdemeanor on the first offense and a
felony for each subsequent offense (Sec. 63-465.19, 1966 amendment).
Rhode Island -- General Laws of Rhode Island, Vol. 4,
Sections 21-29-1 to 21-29-23.
Rhode Island controls stimulants and depressants (Sec. 2129-2). Important unlawful acts are: (1) illegal possession;
(2) illegal sale or distribution; and (3) failure to keep records
(Sec. 21-29-3). Records of inventory and sales must be kept for
two years (Sec. 21-29-8 and 21-29-9). Records are open to inspectors (Sec. 21-29-10). All unlawfully possessed stimulants or
depressants are contraband and subject to seizure (Sec. 21-29-11).
Any vessel, vehicle, or aircraft used in transportation of contraband is subject to forfeiture (Sec. 21-29-12). The board of
pharmacy has the authority to make rules and regulations necessary
to carry out provision of this law (Sec. 21-29-17). Any licensed
physician or pharmacist violating this act may have his license
suspended or revoked (Sec. 21-29-19). Unlawful sale of stimulants
or depressants to a minor is a felony (Sec. 21-29-20). For violation of the general provisions of the law the penalty for first
offense is a misdemeanor and each subsequent offense a felony
(Sec. 21-29-21) .
South Dakota -- South Dakota Code, 1960 Supp., Titl~ 22,
Chapter 22.13A, Sections 22.13A01 to 22.13A09 as amended by chapter
106 Session Laws of South Dakota 1965.
Controlled drugs in South Dakota are depressants and stimulants (Sec. 22.13A02 and 22.13Al0). Important unlawful acts include: (1) illegal sale or distribution; (2) illegal possession;
and (3) failure to keep records (Secs. 22.13A03 and 22.13All).
Records are to be kept for two years (Sec. 22.13A06), and records
are to be open to inspection b) authorized agents of the state
board of health (Sec. 22.13A07. Penalties for violation of this
law are a misdemeanor on first offense and a felony for each subsequent offense (Sec. 22.9933).
Wisconsin -- Wisconsin Statutes 1965, Vol. 1, Chapter 151,
Section 151.07.
Dangerous drugs controlled in Wisconsin are stimulants and
depressants (Sec. 151.07 (1) (a). Sale and possession of illegal
dangerous drugs is prohibited (Sec. 151.07 (4), 151.07 (7). The
state board of pharmacy is the administrator of the law (Sec.
151.07 (9). Penalty for violation of the law is a misdemeanor
(Sec. 151.07 (10).

*

In the compilation of dangerous drug laws of states, pages 46
through 56, the following shall apply: _unless otherwis~ stated
a misdemeanor is any penalty with a maximum of $1,000 fine or
one year imprisonment or both; unless otherwise stated, a felony
is any penalty over $1,000 fine or one year imprisonment or both.
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